Edgar Filing: VISHAY INTERTECHNOLOGY INC

As filed with the Securities and Exchange Commission on February 20, 2004

Registration No. 333-102507

-------------------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
---------------
AMENDMENT NO. 4 TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
----------------
VISHAY INTERTECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Delaware 3670 38-1686453
(State or other (Primary Standard (I.R.S. Employer
jurisdiction of Industrial Identification Number)
incorporation or Classification Code
organization) Number)
---------------
Richard N. Grubb
Vishay Intertechnology, Inc.
63 Lincoln Highway
Malvern, Pennsylvania 19355-2120
(610) 644-1300
(Address, including zip code, and telephone number, including area code,
of Registrant's principal executive offices)
-----------------

Copy to:
Abbe L. Dienstag, Esq.
Kramer Levin Naftalis & Frankel LLP
919 Third Avenue
New York, New York 10022
(212) 715-9100
(Name, address, including zip code, and telephone number, including area
code, of agent for service)
----------------

Approximate Date of Commencement of Proposed Sale to the Public: From time
to time after the effective date of this Registration Statement.
----------------

If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, check the following box.
|_|

If any of the securities being registered on this form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. |X|

If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. |_|

If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |_|

If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. |_|

-----------

The registrant hereby amends this registration statement on such date or dates
as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this registration statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until the registration statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.

Preliminary Prospectus, Subject to Completion, dated February 20, 2004

(Vishay logo)

Vishay Intertechnology, Inc.

Class A Warrants to purchase 7,000,000 shares of Common Stock

Class B Warrants to purchase 1,823,529 shares of Common Stock

6,176,467 shares of Common Stock issuable upon exchange of
$105,000,000 of Vishay's Floating Rate Unsecured Loan Notes Due 2102

8,823,529 shares of Common Stock issuable upon exercise of
the Class A Warrants and the Class B Warrants

This prospectus will be used by the selling securityholders to resell all
or a portion of the following securities issued in connection with our
acquisition of BCcomponents Holdings, B.V. in December 2002:

o Class A Warrants to purchase up to 7,000,000 shares of our common stock
at an exercise price of $20.00 per share;

o Class B Warrants to purchase up to 1,823,529 shares of our common stock
at an exercise price of $30.30 per share;

o Up to 6,176,467 shares of our common stock issuable upon exchange of
our floating rate unsecured loan notes due 2102 in the principal amount
of $105,000,000 (or any replacement notes issued in connection with any
spin-off transaction); and

o Up to 8,823,529 shares of our common stock issuable upon exercise of
the warrants, but only by the initial holders of the warrants and their
affiliates or in an underwritten public offering.

In addition, this prospectus covers the issuance of up to 8,823,529 shares
of our common stock upon the exercise of the class A warrants or the class B
warrants by the holders of these warrants, including the initial holders of the
warrants and their affiliates. The initial holders of the warrants and their
affiliates were not permitted to exercise the warrants before the first
anniversary of the date the warrants were issued.

-------------------

Our shares of common stock trade on the New York Stock Exchange under the
symbol "VSH". On February 19, 2004, the last sale price of the shares as
reported on the New York Stock Exchange was $23.47 per share.

Investing in our securities involves risks that are described in the "Risk
Factors" section beginning on page 5 of this prospectus.

We will not receive any cash proceeds from sale of the selling
securityholders' securities, but we will receive the proceeds from the exercise
of the warrants.

Neither the Securities and Exchange Commission, any state securities
commission nor any other regulatory body has approved or disapproved of these
securities or determined if this prospectus is truthful or complete. Any
representation to the contrary is a criminal offense.

The information in this prospectus is not complete and may be changed. We
may not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to sell these securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not permitted.

The date of this prospectus is ,2004.

Important Notice about the Information Presented in this Prospectus

You should rely only on the information contained or incorporated by
reference in this prospectus. We have not authorized any other person to provide
you with different information. If anyone provides you with different or
inconsistent information, you should not rely on it. We are not making an offer
to sell these securities in any jurisdiction where the offer or sale is not
permitted.

You should assume that the information appearing in this prospectus is
accurate as of the date on the front cover of this prospectus only. The
business, financial condition, results of operations and prospects of Vishay may
have changed since that date.

TABLE OF CONTENTS

PROSPECTUS SUMMARY...........................................................1
FORWARD LOOKING INFORMATION..................................................4
RISK FACTORS.................................................................5
RECENT DEVELOPMENTS.........................................................10
USE OF PROCEEDS.............................................................11
DESCRIPTION OF CAPITAL STOCK................................................11
DESCRIPTION OF THE WARRANTS.................................................13
REGISTRATION RIGHTS.........................................................21
CERTAIN UNITED STATES
FEDERAL TAX CONSEQUENCES....................................................23
SELLING SECURITYHOLDERS.....................................................27
PLAN OF DISTRIBUTION........................................................28
LEGAL MATTERS...............................................................31
EXPERTS.....................................................................31
WHERE YOU CAN FIND MORE INFORMATION.........................................31

PROSPECTUS SUMMARY

You should read this entire prospectus, including the information set
forth under "Risk Factors" and the information incorporated by reference in this
prospectus. As used in this prospectus, "Vishay," "company," "we," "us" and
"our" refer to Vishay Intertechnology, Inc. and its consolidated subsidiaries,
unless otherwise specified.

Vishay Intertechnology, Inc.

Vishay Intertechnology, Inc. is a leading international manufacturer and
supplier of passive and active electronic components. Passive components include
resistors, capacitors, transducers and inductors. Our offering of active
components includes discrete semiconductors, diodes, rectifiers, infrared data
communications devices and power and analog switching circuits. Passive
electronic components and discrete active electronic components, together with
integrated circuits, are the primary elements of almost every electronic
circuit. We offer our customers "one-stop" access to one of the most
comprehensive electronic component lines of any manufacturer in the United
States, Europe and Asia. Our components are used in virtually all types of
electronic products, including those in the industrial, automotive, consumer
electronics, telecommunications, electronics manufacturing services, computer
and military/aerospace markets. We had total net sales of $1.82 billion in 2002
and total net sales of $2.17 billion in 2003.

In the past two years, we have taken advantage of the downturn in the
electronics industry and the strength of our balance sheet to acquire businesses
at prices that we believe would not have been available in other economic
environments. In December 2002, we acquired BCcomponents Holdings, a leading
manufacturer of passive components in Europe, India and the People's Republic of
China, with a broad portfolio of products. Also in 2002, our Measurements Group
acquired five manufacturers of transducers and related products that are used in
the measurement of stresses, loads, forces and pressure. In November 2001, we
acquired General Semiconductor, Inc., a manufacturer of rectifiers, power
management devices and other discrete semiconductor components. These
acquisitions have broadened our product lines, cushioned the effects of the
current downturn and, we believe, helped position our company for growth.

Our long-term objective is to expand our position as a low-cost producer
of a comprehensive line of electronic components. We are led by our founder, Dr.
Felix Zandman, and senior executives who collectively have over 150 years of
service to Vishay. This management team is focused on continued implementation
of our growth strategy, through which we intend to:

o expand within the electronic components industry, primarily through
the acquisition of other manufacturers of electronic components that
have established positions in major markets, reputations for product
quality and reliability, and product lines with which we have
substantial marketing and technical expertise;

o achieve a leading position in the market for each of our major product
lines;

o reduce selling, general and administrative expenses through the
integration or elimination of redundant sales offices and
administrative functions at acquired companies;

o achieve significant production cost savings through the transfer to
and expansion of manufacturing operations in regions such as Israel,
Mexico, Portugal, the Czech Republic, Malaysia, the Republic of China
(Taiwan) and the People's Republic of China, which offer lower labor
costs and tax and other government-sponsored incentives;

o maintain significant production facilities in those regions where we
market our products to service our customers;

o consistently develop, introduce and market new and innovative
products; and

o strengthen our relationships with customers.

We were incorporated in Delaware in 1962 and maintain our principal
executive offices at 63 Lincoln Highway, Malvern, Pennsylvania 19355-2143. Our
telephone number is (610) 644-1300.

We have two classes of stock: common stock that has one vote per share and
Class B common stock that has 10 votes per share. Only the common stock is
publicly traded. The Class B common stock is privately held. All references in
this prospectus to common stock are to our publicly traded common stock and not
to the Class B common stock.

The Offering

In connection with our acquisition of BCcomponents Holdings, B.V. in
December 2002, we acquired all of the outstanding shares of BCcomponents
Holdings B.V. in exchange for class A warrants and class B warrants to acquire
an aggregate of 8,823,529 shares of our common stock. In addition, in connection
with the acquisition, $105 million in principal amount of BCcomponents'
mezzanine indebtedness and certain other securities of BCcomponents were
exchanged for $105 million principal amount of our floating rate unsecured notes
due 2102. We entered into a put and call agreement related to the notes. In
addition, we granted to the recipients of the notes and the warrants certain
registration rights. This prospectus has been prepared, and the registration
statement of which this prospectus is a part has been filed with the Securities
and Exchange Commission, to satisfy our obligations to the recipients of the
notes and the warrants. Accordingly, this prospectus covers:

o the resale by selling securityholders of the class A warrants and the
class B warrants;

o the resale by selling securityholders of shares of our common stock
issuable upon exchange of the notes;

o the resale by selling securityholders of shares of our common stock
issuable upon exercise of the warrants, but only by the initial holders
of the warrants or their affiliates or in an underwritten public
offering where the warrants are exercised in connection with the
offering, or in certain other circumstances; and

o the issuance by us of shares of our common stock upon exercise of the
warrants by holders.

For a description of our acquisition of BCcomponents, see our Current
Report on Form 8-K filed December 23, 2002 and our Current Report on Form 8-K/A
filed February 26, 2003.

Investing in our securities involves risks. You should carefully consider
the information under "Risk Factors" beginning on page 5 and the other
information included in this prospectus before investing in our securities.

Warrants

The class A warrants give the holders the right to purchase up to an
aggregate of 7,000,000 shares of our common stock at an exercise price of $20.00
per share. The class B warrants give the holders the right to purchase up to an
aggregate of 1,823,529 shares of our common stock at an exercise price of $30.30
per share. Both the number of shares for which the class A warrants and the
class B warrants are exercisable and their respective exercise prices are
subject to specified anti-dilution and transactional adjustments. The class A
warrants and the class B warrants each have a 10-year term expiring on December
13, 2012.

The warrants may be exercised at any time from and after the date the
warrants were issued until the expiration date by any holder other than an
initial holder of the warrants or an affiliate of an initial holder. The
warrants may be exercised at any time from and after December 13, 2003, the
first anniversary of the date the warrants were issued, until the expiration
date by an initial holder of the warrants or an affiliate of an initial holder.

Pursuant to a securities investment and registration rights agreement that
we entered into at the time of our acquisition of BCcomponents, we agreed to
register the class A warrants and the class B warrants held by the selling
securityholders together with the shares of our common stock issuable upon
exercise of the class A warrants and the class B warrants pursuant to the
Securities Act of 1933, as amended, to facilitate the public sale of those
warrants.

Common Stock

Shares issuable on exchange of notes

In connection with our acquisition of BCcomponents, we entered into a put
and call agreement with the holders of our floating rate unsecured notes due
2102. Among other things, this agreement provides that holders of the notes may
"put" or exchange the notes for our common stock, at a ratio of one share of our
common stock, for each $17.00 principal amount of the notes. A total of
6,176,467 shares of our common stock are issuable upon exchange of the
$105,000,000 principal amount of notes outstanding, subject to anti-dilution and
transactional adjustments. These shares are being offered through this
prospectus for sale by the selling securityholders following exchange of the
notes in the manner described under "Plan of Distribution."

Shares issuable on exercise of warrants

We are offering through this prospectus the 7,000,000 shares of our common
stock issuable upon exercise of the class A warrants and the 1,823,529 shares of
our common stock issuable upon exercise of the class B warrants to the holders
of the warrants upon exercise. As a result, the shares issuable upon exercise of
the warrants will be freely tradeable under the United States securities laws,
other than by holders who are our affiliates.

In addition, the selling securityholders may offer the shares issuable
upon exercise of the warrants for resale through this prospectus, but only if
they are the initial holders of the warrants or affiliates of the initial
holders or if the shares are being offered for resale in an underwritten public
offering where the warrants are being exercised in connection with the offering.

Other holders of the warrants may only sell the common stock underlying
the warrants pursuant to the prospectus:

o in an underwritten public offering, where the warrants are being
exercised in connection with the offering; or

o if for any reason our registration of the shares of common stock
issuable upon exercise of the warrants is not effective.

FORWARD LOOKING INFORMATION

Some of the statements in this prospectus and in documents incorporated by
reference constitute forward-looking statements. These forward-looking
statements reflect our current views with respect to future events or our
financial performance, and involve certain known and unknown risks,
uncertainties and other factors, including those identified below, which may
cause our or our industry's actual or future results, levels of activity,
performance or achievements to differ materially from those expressed or implied
by any forward-looking statements or from historical results. In some cases, you
can identify forward-looking statements by terminology such as "may," "will,"
"could," "would," "should," "believe," "expect," "plan," "anticipate," "intend,"
"estimate," "predict," "potential" and other expressions which indicate future
events and trends. We have no duty to update or revise any forward-looking
statements after the date of this prospectus or to conform them to actual
results, new information, future events or otherwise.

The following factors, among others, could cause our or our industry's
future results to differ materially from historical results or those
anticipated:

o overall economic and business conditions;

o competitive factors in the industries in which we conduct our
business;

o changes in governmental regulation;

o the demand for our goods and services;

o the fact that our customers may cancel orders they have placed with
us, in whole or in part, without advance notice;

o changes in tax requirements, including tax rate changes, new tax laws
and revised tax law interpretations;

o changes in generally accepted accounting principles or interpretations
of those principles by governmental agencies and self-regulatory
groups;

o developments in and results of litigation;

o interest rate fluctuations, foreign currency rate fluctuations and
other capital market conditions;

o economic and political conditions in international markets, including
governmental changes and restrictions on the ability to transfer
capital across borders;

o changes in the cost of raw materials used in our business;

o the timing, impact and other uncertainties of acquisitions that we may
consider or consummate; and

o our ability to achieve anticipated synergies and other cost savings in
connection with such acquisitions.

These factors and the risk factors described in this document are all of
the important factors of which we are aware that could cause actual results,
performance or achievements to differ materially from those expressed in any of
our forward-looking statements. We operate in a continually changing business
environment, and new risk factors emerge from time to time. Other unknown or
unpredictable factors also could have material adverse effects on our future
results, performance or achievements. We cannot assure you that projected
results or events will be achieved or will occur.

RISK FACTORS

You should carefully consider the following information with the other
information contained or incorporated by reference in this prospectus.

Risk factors related to our business generally.

Our business is cyclical and the current decline in demand in the electronic
component industry may continue and may become more pronounced.

We and others in the electronic and semiconductor component industry have
for the past several years experienced a decline in product demand on a global
basis, resulting in order cancellations and deferrals, lower average selling
prices, and a material and adverse impact on our results of operations. This
decline was primarily attributable to a slowing of growth in the personal
computer and cellular telephone product markets. We have seen indications of
improvements in the economy and electronic and semiconductor component industry
and expect improvements in 2004. However, such expected or perceived
improvements in the economy and the electronic and semiconductor component
industry may not materialize. The slowdown may continue and may become more
pronounced. A slowdown in demand, as well as recessionary trends in the global
economy, make it more difficult for us to predict our future sales, which also
makes it more difficult to manage our operations, and could adversely impact our
results of operations.

We have incurred and may continue to incur restructuring costs.

To remain competitive, particularly when business conditions are
difficult, we attempt to reduce our cost structure through restructuring
activities. This includes acquisition-related restructuring, where we attempt to
streamline the operations of companies we acquire and achieve synergies between
our acquisitions and our existing business. It also includes restructuring our
existing businesses, where we seek to eliminate redundant facilities and staff
positions and move operations, where possible, to jurisdictions with lower labor
costs. In 2002, we recorded restructuring costs of approximately $48 million
related to acquisitions and $31 million related to our existing businesses. We
incurred approximately $29.6 million of additional restructuring and severance
costs in 2003 and expect to continue to incur such costs during 2004.

In the past we have grown through acquisitions but this may not continue.

Our long-term historical growth in revenues and net earnings has resulted
in large part from our strategy of expansion through acquisitions. We cannot
assure you, however, that we will identify or successfully complete transactions
with suitable acquisition candidates in the future. We also cannot assure you
that acquisitions that we complete in the future will be successful. If an
acquired business fails to operate as anticipated or cannot be successfully
integrated with our other businesses, our results of operations, enterprise
value, market value and prospects could all be materially and adversely
affected.

Our debt levels have recently increased, which could adversely affect the
perception in the financial markets of our financial condition.

Our outstanding debt increased from approximately $141 million at the end
of 2000 to approximately $838 million at the end of 2003. This increase reflects
our issuance in August 2003 of $500 million in principal amount of 3 5/8%
convertible subordinated notes due 2023, net of debt repaid with the proceeds of
this issuance. It also reflects our acquisition activity, particularly the
acquisition of General Semiconductor, Inc. in November 2001, in which we assumed
approximately $170 million in convertible notes issued by General Semiconductor
and $85 million in bank debt, and the acquisition of BCcomponents in December
2002, in which we issued or assumed indebtedness of approximately $275 million.
The increase in indebtedness was offset somewhat by the repayment of outstanding
debt with cash from operations. The marketplace could react negatively to our
current debt levels which in turn could affect our share price and also make it
more difficult for us to obtain financing in the future. Our higher debt level
was one of the factors cited by Moody's Investor Services, Inc. when it
announced in April 2003 that it had lowered our debt ratings. On July 31, 2003,
Moody's announced that it had upwardly revised its ratings of our debt based on
its belief that the restructuring of our credit facility and the issuance of the
3 5/8% convertible notes

alleviates short term liquidity concerns. On October 31, 2003, Moody's announced
that it had downgraded our ratings, citing what it termed the continuing
weakness in our business, particularly our passives business, and the
possibility of further special charges, particularly in connection with our
tantalum purchase commitments.

In June 2004, holders of our Liquid Yield Option(TM) Notes (LYONs) will
have the right to "put" these notes to us at an aggregate price of approximately
$235 million, giving effect to our repurchase of a portion of the LYONs with
proceeds from our sale of the 3 5/8 convertible notes. We believe that, if
necessary, we will have adequate cash resources to finance the purchase of any
LYONs that are put to us. Also, we may elect to pay all or part of the purchase
price for the LYONs that are put to us in shares of our common stock.
Nevertheless, our obligation to purchase the LYONs in June 2004 could be a cause
of concern in the financial markets and was another factor cited by Moody's when
it downgraded our debt.

To remain successful, we must continue to innovate.

Our future operating results are dependent on our ability to continually
develop, introduce and market new and innovative products, to modify existing
products, to respond to technological change and to customize certain products
to meet customer requirements. There are numerous risks inherent in this
process, including the risks that we will be unable to anticipate the direction
of technological change or that we will be unable to develop and market new
products and applications in a timely fashion to satisfy customer demands. If
this occurs, we could lose customers and experience adverse effects on our
financial condition and results of operations.

Future acquisitions could require us to issue additional indebtedness or equity.

If we were to undertake a substantial acquisition for cash, the
acquisition would likely need to be financed in part through bank borrowings or
the issuance of public or private debt. This acquisition financing would likely
decrease our ratio of earnings to fixed charges and adversely affect other
leverage criteria. Under our existing credit facility, we are required to obtain
the lenders' consent for certain additional debt financing and to comply with
other covenants including the application of specific financial ratios. We are
also restricted from paying cash dividends on our capital stock. We cannot
assure you that the necessary acquisition financing would be available to us on
acceptable terms when required. If we were to undertake an acquisition for
equity, the acquisition may have a dilutive effect on the interests of the
holders of our common stock.

Our results are sensitive to raw material availability, quality and cost.

General: Many of our products require the use of raw materials that are
produced in only a limited number of regions around the world or are available
from only a limited number of suppliers. Our results of operations may be
materially and adversely affected if we have difficulty obtaining these raw
materials, the quality of available raw materials deteriorates or there are
significant price increases for these raw materials. For example, the prices for
tantalum and palladium, two raw materials that we use in our capacitors, are
subject to fluctuation. For periods in which the prices of these raw materials
are rising, we may be unable to pass on the increased cost to our customers
which would result in decreased margins for the products in which they are used.
For periods in which the prices are declining, we may be required to write down
our inventory carrying cost of these raw materials, since we record our
inventory at the lower of cost or market. Depending on the extent of the
difference between market price and our carrying cost, this write-down could
have a material adverse effect on our net earnings. As discussed below, we have
recorded substantial write-downs of tantalum and palladium in the current
economic downturn.

From time to time there have been short-term market shortages of raw
materials. While these shortages have not historically adversely affected our
ability to increase production of products containing tantalum and palladium,
they have historically resulted in higher raw material costs for us. We cannot
assure you that any of these market shortages in the future would not adversely
affect our ability to increase production, particularly during periods of
growing demand for our products.

-----------------------------------------
(TM) Trademark of Merrill Lynch & Co., Inc.

Tantalum: We are a major consumer of the world's annual production of
tantalum. Tantalum, a metal purchased in powder or wire form, is the principal
material used in the manufacture of tantalum capacitors. There are currently
three major suppliers that process tantalum ore into capacitor grade tantalum
powder. Due to the strong demand for our tantalum capacitors and difficulty in
obtaining sufficient quantities of tantalum powder from our suppliers, we
stockpiled tantalum ore in 2000 and early 2001. During 2001, we experienced a
significant decrease in sales due to declining orders and the deferral or
cancellation of existing orders. Our tantalum capacitor business was
particularly impacted by the slowdown in sales. Prices for tantalum ore and
powder decreased during this period. As a result, we recorded write-downs of
$52,000,000 on tantalum during 2001.

In June 2002, we agreed with Cabot Corporation to amend our two tantalum
supply agreements for the supply by Cabot to us of tantalum powder and wire.
Pursuant to the amendments, we and Cabot agreed to reduce volumes, and starting
in 2003, prices of tantalum products under the agreements and to extend the term
of one of the agreements by one year. We also agreed to purchase tantalum
products at regular intervals over the term of the agreements. These amendments
require us to purchase tantalum products in excess of our current usage
requirements.

In the fourth quarter of 2002, we took charges of approximately $106
million against our contractual commitments to purchase tantalum powder and wire
from Cabot through 2006 and wrote-down approximately $25.7 million of our
existing inventory of tantalum ore, powder and wire to present market value. In
2003, we took additional charges of approximately $11.4 million against our
contractual commitments to purchase tantalum powder and wire from Cabot, and
wrote-down inventory on hand by approximately $5.4 million to present market
value. We did this because the current market prices of tantalum are
substantially below the prices at which we are committed to purchase tantalum
under our long-term contracts with Cabot and the prices at which we were
carrying our tantalum raw materials inventory. If market prices for tantalum
were to decline further, we could be required to record additional write-downs
on our tantalum purchase commitments and inventory.

Palladium: Palladium, a metal used to produce multi-layered ceramic
capacitors, is currently found primarily in South Africa and Russia. Palladium
is a commodity product subject to price volatility. The price of palladium has
fluctuated in the range of approximately $148 to $1,090 per troy ounce during
the last three years. As of December 31, 2003, the price of palladium was
approximately $195 per troy ounce. During 2003, 2002 and 2001, we recorded
write-downs on our palladium inventories of $1.6 million, $1.7 million and $18
million, respectively.

Our backlog is subject to customer cancellation.

As of December 31, 2003, our backlog was $532 million. Many of the orders
that comprise our backlog may be canceled by our customers without penalty. Our
customers may on occasion double and triple order components from multiple
sources to ensure timely delivery when backlog is particularly long. They often
cancel orders when business is weak and inventories are excessive, a phenomenon
that we have experienced in the current economic slowdown. Therefore, we cannot
be certain the amount of our backlog does not exceed the level of orders that
will ultimately be delivered. Our results of operations could be adversely
impacted if customers cancel a material portion of orders in our backlog.

We face intense competition in our business, and we market our products to an
increasingly concentrated group of customers.

Our business is highly competitive worldwide, with low transportation
costs and few import barriers. We compete principally on the basis of product
quality and reliability, availability, customer service, technological
innovation, timely delivery and price. The electronics components industry has
become increasingly concentrated and globalized in recent years and our major
competitors, some of which are larger than us, have significant financial
resources and technological capabilities.

Our customers have become increasingly concentrated in recent years, and
as a result, their buying power has increased and they have had greater ability
to negotiate favorable pricing. This trend has adversely affected our average
selling prices, particularly for commodity components.

We may not have adequate facilities to satisfy future increases in demand for
our products.

Our business is cyclical and in periods of a rising economy, we may
experience intense demand for our products. During such periods, we may have
difficulty expanding our manufacturing to satisfy demand. Factors which could
limit such expansion include delays in procurement of manufacturing equipment,
shortages of skilled personnel and capacity constraints at our facilities. If we
are unable to meet our customers' requirements and our competitors sufficiently
expand production, we could lose customers and/or market share. This loss could
have an adverse effect on our financial condition and results of operations.

Future changes in our environmental liability and compliance obligations may
harm our ability to operate or increase costs.

Our manufacturing operations, products and/or product packaging are
subject to environmental laws and regulations governing air emissions,
wastewater discharges, the handling, disposal and remediation of hazardous
substances, wastes and certain chemicals used or generated in our manufacturing
processes, employee health and safety labeling or other notifications with
respect to the content or other aspects of our processes, products or packaging,
restrictions on the use of certain materials in or on design aspects of our
products or product packaging and responsibility for disposal of products or
product packaging. We establish reserves for specifically identified potential
environmental liabilities which we believe are adequate. Nevertheless, we often
unavoidably inherit certain pre-existing environmental liabilities, generally
based on successor liability doctrines. Although we have never been involved in
any environmental matter that has had a material adverse impact on our overall
operations, there can be no assurance that in connection with any past or future
acquisition we will not be obligated to address environmental matters that could
have a material adverse impact on our operations. In addition, more stringent
environmental regulations may be enacted in the future, and we cannot presently
determine the modifications, if any, in our operations that any such future
regulations might require, or the cost of compliance with these regulations. In
order to resolve liabilities at various sites, we have entered into various
administrative orders and consent decrees, some of which may be, under certain
conditions, reopened or subject to renegotiations.

Our products may experience a reduction in product classification levels under
various military specifications.

We have qualified certain of our products under various military
specifications, approved and monitored by the United States Defense Electronic
Supply Center, and under certain European military specifications. These
products are assigned certain classification levels. In order to maintain the
classification level of a product, we must continuously perform tests on the
product and the results of these tests must be reported to governmental
agencies. If any of our products fails to meet the requirements of the
applicable classification level, that product's classification may be reduced to
a lower level. A decrease in the classification level for any of our products
with a military application could have an adverse impact on the net sales and
earnings attributable to that product.

Risk factors relating to Vishay's operations outside the United States

We obtain substantial benefits by operating in Israel, but these benefits may
not continue.

We have increased our operations in Israel over the past several years.
The low tax rates in Israel applicable to earnings of our operations in that
country, compared to the rates in the United States, have had the effect of
increasing our net earnings, although this was not the case in 2002. Also, we
have benefited from employment incentive grants made by the Israeli government.
Recently, the Israeli government suspended payment on one of these grants after
we were forced to lay off a significant number of employees as a result of the
current economic downturn. Although we reached agreement with the Israeli
government to resume payment on this grant, there can be no assurance that we
will maintain our eligibility for this or other existing project grants. There
can also be no assurance in the future the Israeli government will continue to
offer new grant and tax incentive programs applicable to us or that, if it does,
such programs will provide the same level of benefits we have historically
received or that we will continue to be eligible to take advantage of them. Any
significant increase in the Israeli tax rates or reduction or elimination of the
Israeli grant programs that have benefited us could have an adverse impact on
our results of operations.

We attempt to improve profitability by operating in countries in which labor
costs are low, but the shift of operations to these regions may entail
considerable expense.

Our strategy is aimed at achieving significant production cost savings
through the transfer and expansion of manufacturing operations to and in
countries with lower production costs, such as Israel, Mexico, Portugal, the
Czech Republic, Malaysia, the Republic of China (Taiwan) and the People's
Republic of China. In this process, we may experience under-utilization of
certain plants and factories in high labor cost regions and capacity constraints
in plants and factories located in low labor cost regions. This
under-utilization may result initially in production inefficiencies and higher
costs. These costs include those associated with compensation in connection with
work force reductions and plant closings in the higher labor cost regions, and
start-up expenses, manufacturing and construction delays, and increased
depreciation costs in connection with the initiation or expansion of production
in lower labor cost regions.

As we implement transfers of certain of our operations we may experience
strikes or other types of labor unrest as a result of lay-offs or termination of
our employees in high labor cost countries.

We are subject to the risks of political, economic and military instability in
countries outside the United States in which we operate.

We have operations outside the United States, and approximately 74% of our
revenues during 2003 were derived from sales to customers outside the United
States. Some of the countries in which we operate have in the past experienced
and may continue to experience political, economic and military instability or
unrest. These conditions could have an adverse impact on our ability to operate
in these regions and, depending on the extent and severity of these conditions,
could materially and adversely affect our overall financial condition and
operating results. In particular, current tensions in the Middle East could
adversely affect our business operations in Israel and elsewhere.

Our business was affected by the outbreak of SARS in 2003 and the effects of
that outbreak may linger.

The outbreak of severe acute respiratory syndrome, or SARS, that began in
the People's Republic of China adversely affected our business during the first
six months of 2003, particularly in Asia where we derived approximately 36% and
38% of our revenue in 2003 and 2002, respectively. This impact included
disruptions in the operations of our customers, a slowdown in customer orders
and reduced sales in certain end markets. If the outbreak of SARS or like
diseases were to recur in Asia on a comparable level, we could experience
similar disruptions to our business.

Risk factors relating to Vishay's capital structure

The holders of our Class B common stock have voting control of Vishay.

The holders of our Class B common stock have voting control of Vishay. We
have two classes of common stock: common stock and Class B common stock. The
holders of our common stock are entitled to one vote for each share held, while
the holders of our Class B common stock are entitled to 10 votes for each share
held. Currently, the principal holder of our Class B common stock, our chairman
and chief executive officer, controls approximately 50.5% of our outstanding
voting power. As a result, this holder of Class B common stock can cause the
election of directors and approve other actions as a stockholder without the
approval of other stockholders of Vishay.

The existence of our Class B common stock may deprive other stockholders of a
premium value for their shares in a takeover.

The control that holders of our Class B common stock have over our company
may make us less attractive as a target for a takeover proposal. It may also
make discourage a merger proposal or foreclose a proxy contest for the removal
of the incumbent directors, even if such actions were favored by a substantial
majority of our stockholders other than the holders of our Class B common stock.
Accordingly, this may deprive the holders of our common stock of an opportunity
they might otherwise have to sell their shares at a premium over the prevailing
market price in connection with a merger or acquisition of Vishay with or by
another company.

We have a staggered board of directors which could make a takeover of Vishay
difficult.

At our most recent annual meeting of stockholders, our stockholders
approved a proposal to stagger our board of directors. A staggered board of
directors might discourage, delay or prevent a change in control of our company
by a third party and could discourage proxy contests and make it more difficult
for our stockholders to elect directors and take other corporate actions. Also,
as a consequence of our staggered board, directors may not be removed without
cause, even though a majority of stockholders may wish to do so.

Risk factors relating to the offering

There may be no active trading market for the warrants.

Before the offering, there has been no established trading market for our
class A warrants or our class B warrants. We do not intend to list the warrants
on a national securities exchange or seek admission of the warrants for
quotation through any automated quotation system. Moreover, we cannot assure you
as to the development or liquidity of any market for the warrants, the ability
of the warrant holders to sell their warrants or any portion of those warrants
or the price at which holders would be able to sell their warrants or any
portion of those warrants.

Exchange of the notes or exercise of the warrants will dilute the ownership
interests of existing stockholders.

The exchange of some or all of the notes or the exercise of some or all of
the warrants will dilute the ownership interests of existing stockholders and
any sales in the public market of the shares of our common stock issuable upon
such exchange or exercise could adversely affect prevailing market prices of our
common stock. In addition, the existence of the warrants may encourage short
selling by market participants because exercise of the warrants could depress
the price of our common stock.

RECENT DEVELOPMENTS

Results for the Quarter and Year Ended December 31, 2003

On February 6, 2004, we announced our unaudited financial results for the
quarter and year ended December 31, 2003. Sales for the quarter ended December
31, 2003 were $567.2 million, as compared to sales of $459.4 million for the
quarter ended December 31, 2002. Net earnings for the quarter ended December 31,
2003 were $10.3 million, or $0.06 per share, compared with a net loss for the
quarter ended December 31, 2002 of $123.8 million or $0.78 per share. Earnings
for the quarter ended December 31, 2003 were impacted by restructuring and
severance costs of $10.3 million and a write-down of tantalum inventories on
hand to market value of $1.2 million, offset by a gain on an insurance claim of
$3.5 million. The quarter ended December 31, 2002 included charges for
restructuring, inventory write-downs, a loss on purchase commitments, and other
charges of $162.4 million. Our book-to-bill ratio for the fourth quarter was
1.14, reflecting a book-to-bill for our actives business of 1.23 and a
book-to-bill for our passives business of 1.06. Our backlog was $532 million at
December 31, 2003.

Sales for the year ended December 31, 2003 were $2.171 billion compared to
sales of $1.823 billion for the year ended December 31, 2002. Net earnings for
the year ended December 31, 2003 were $26.8 million, or $0.17 per share,
compared with a net loss for the year ended December 31, 2002 of $92.6 million,
or $0.58 per share. Earnings for the year ended December 31, 2003 were impacted
by restructuring and severance costs of $29.6 million, a loss on extinguishment
of debt of $9.9 million, a loss on long-term purchase commitments of $11.4
million, and a write-down of tantalum inventories on hand to market value of
$5.4 million, offset by a gain on an insurance claim of $33.9 million. The year
ended December 31, 2002 included charges for restructuring, inventory
write-downs, a loss on purchase commitments and other charges of $169.9 million.

USE OF PROCEEDS

We will not receive any cash proceeds from the sale of warrants or our
common stock by the selling securityholders.

If the class A warrants are exercised in full, we would realize proceeds,
before expenses, in the amount of $140,000,000. If the class B warrants are
exercised in full, we would realize proceeds, before expenses, in the amount of
$55,252,928. If we spin off a subsidiary or business unit, any warrants then
outstanding, under certain circumstances, would be exchanged in part for
warrants of the spin-off entity. In that case, the amount of proceeds that we
would realize upon exercise of the warrants would be lower.

The net proceeds of the exercise of the warrants will be used to pay down
any outstanding debt on our revolving credit facility that may exist at the time
and for general corporate purposes.

DESCRIPTION OF CAPITAL STOCK

The aggregate number of shares of capital stock which Vishay has authority
to issue is 341,000,000 shares: 1,000,000 shares of preferred stock, par value
$1.00 per share, 300,000,000 shares of common stock, par value $0.10 per share,
and 40,000,000 shares of Class B common stock, par value $0.10 per share. No
shares of preferred stock have been issued. At February 18, 2004, there were
145,531,124 shares of common stock and 14,979,440 shares of Class B common stock
outstanding.

Common Stock

After any required payment on shares of preferred stock, holders of common
stock and Class B common stock are entitled to receive, and share ratably on a
per share basis in, all dividends and other distributions declared by the board
of directors of Vishay. In the event of a stock dividend or stock split, holders
of common stock will receive shares of common stock and holders of Class B
common stock will receive shares of Class B common stock. Neither the common
stock nor the Class B common stock may be split, divided or combined unless the
other is split, divided or combined equally.

The holders of common stock are entitled to one vote for each share held.
Holders of Class B common stock are entitled to 10 votes for each share held.
The common stock and the Class B common stock vote together as one class on all
matters subject to stockholder approval, except as set forth in the following
sentence. The approval of the holders of common stock and of Class B common
stock, each voting separately as a class, is required to authorize issuances of
additional shares of Class B common stock other than in connection with stock
splits and stock dividends.

Shares of Class B common stock are convertible into shares of our common
stock on a one-for-one basis at any time at the option of the holder thereof.
The Class B common stock is not transferable except to the holder's spouse,
certain of such holder's relatives, certain trusts established for the benefit
of the holder, the holder's spouse or relatives, corporations and partnerships
beneficially owned and controlled by such holder, such holder's spouse or
relatives, charitable organizations and such holder's estate. Upon any transfer
made in violation of those restrictions, shares of Class B common stock will be
automatically converted into shares of our common stock on a one-for-one basis.

Neither the holders of common stock nor the holders of Class B common
stock have any preemptive rights to subscribe for additional shares of capital
stock of Vishay.

Our common stock is listed on the New York Stock Exchange. There is no
public market for shares of our Class B common stock. All outstanding shares of
common stock and Class B common stock are, and upon exchange of the notes or
exercise of the warrants, the shares of common stock issuable upon exchange of
the notes and exercise of the warrants will be, validly issued, fully paid and
non-assessable.

Preferred Stock

Our board of directors is authorized, without further stockholder
approval, to issue from time to time up to an aggregate of 1,000,000 shares of
preferred stock in one or more series. The board of directors may fix or alter
the designation, preferences, rights and any qualification, limitations, or
restrictions of the shares of any series, including the dividend rights,
dividend rates, conversion rights, voting rights, redemption terms and prices,
liquidation preferences and the number of shares constituting any series. No
shares of our preferred stock are currently outstanding.

Other Matters

We have a staggered board of directors, with one third of the board being
elected each year. As a consequence, directors may not be removed other than for
cause.

We are subject to Section 203 of the Delaware General Corporation Law
which prohibits us from engaging in a "business combination" with an "interested
stockholder" for a period of three years after the date of the transaction in
which the person became an interested stockholder, unless the business
combination is approved in a prescribed manner. Generally, an "interested
stockholder" is a person who, together with affiliates and associates, owns or
within three years did own, 15% or more of our voting stock.

We furnish to our stockholders annual reports containing financial
statements certified by an independent public accounting firm.

American Stock Transfer & Trust Company is the transfer agent and
registrar of our common stock and Class B common stock.

Common Stock Offered Pursuant to this Prospectus

The common stock covered by this prospectus includes common stock issuable
upon exercise of the warrants and upon exchange of the notes. For a description
of the warrants, see "Description of the Warrants."

We issued the notes and entered into a related put and call agreement in
connection with the acquisition of BCcomponents to the holders of $105 million
principal amount of mezzanine debt of BCcomponents in exchange for the mezzanine
debt and certain other securities of BCcomponents. The notes were issued
pursuant to the terms of a note purchase agreement and the notes, copies of
which are filed as exhibits to the registration statement of which this
prospectus forms a part and to which reference is made for a definitive
description of the terms of the notes.

The notes bear interest at LIBOR plus 1.5% for any interest period ending
on or prior to December 31, 2006, and LIBOR thereafter. If at any time beginning
on the date of issue of the notes and ending on December 31, 2010 our common
stock trades at a price above $45.00 per share over a specified measuring
period, the interest rate will be reduced for all interest periods beginning on
or after January 1, 2011 to one-half LIBOR. Interest on the notes is payable
quarterly in arrears on March 31, June 30, September 30 and December 31 in each
year beginning on December 31, 2002.

The notes are subject to a put and call agreement executed by us for the
benefit of the holders of the notes. A copy of the put and call agreement is
filed as an exhibit to the registration agreement of which this prospectus forms
a part. Under the agreement, note holders may "put" the notes to us at an
exchange price of one share of our common stock for $17.00 principal amount of
the notes, or 6,176,467 shares of our common stock in the aggregate. We may
similarly call the notes in exchange for shares of our common stock at the same
exchange price at any time beginning on January 2, 2018 and ending on the date
that is 30 days prior to the maturity date of the notes. If the price of our
common stock has not traded above $35.00 per share over a specified measuring
period prior to the call, the number of shares issuable in the call will be the
principal amount of the notes divided by the then current market price for the
shares, or we may call the notes for cash equal to the principal amount of the
notes. Common stock issued in exchange for notes on exercise of the put or the
call will be in satisfaction of our obligation to pay the principal of the notes
and all interest accrued but unpaid to the date of exchange.

Unless the notes are otherwise previously redeemed, repaid or repurchased,
upon maturity at December 31, 2102, we will pay the principal of the notes plus
accrued and unpaid interest up to the maturity date.

The exchange price, and in some cases the cash that we or a successor may
be required to pay, under the put and the call are subject to anti-dilution and
transactional adjustments under the terms of the put and call agreement, to
which reference is made for a description of these adjustments. In the event of
a spin-off transaction of the type described below under "Description of the
Warrants--Adjustments--Spin-offs," other notes of Vishay, having the same terms
and provisions but a lesser principal amount, may be substituted for the notes.
This prospectus covers the shares of our common stock issuable upon exchange of
the replacement notes as well.

DESCRIPTION OF THE WARRANTS

On December 13, 2002, we acquired all of the outstanding shares of
BCcomponents in exchange for class A warrants to acquire 7,000,000 shares of our
common stock at an exercise price of $20.00 per share and class B warrants to
acquire 1,823,529 shares of our common stock at an exercise price of $30.30 per
share. With the exception of the exercise price, the class A warrants and the
class B warrants have identical terms and provisions. Unless otherwise
indicated, we use the term warrants to refer to the class A warrants and the
class B warrants. The following summary description of the warrants sets forth
some general terms and provisions of the warrants, but the summary does not
purport to be complete and is qualified in all respects by reference to the
actual text of the warrants and the warrant agreement, pursuant to which the
warrants were issued, copies of which have been filed as an exhibit to the
registration statement of which this prospectus is a part. We urge you to read
the text of the warrant agreement and the warrants because those documents, and
not this description, define your complete rights as a warrant holder.

Exercise Period

Exercise Price and Other Terms

Each class A warrant entitles its holder to purchase the shares of our
common stock specified on the face of the class A warrant at an exercise price
of $20.00 per share, and each class B warrant entitles its holder to purchase
the shares of our common stock specified on the face of the class B warrant at
an exercise price of $30.30 per share. The exercise price of the warrants is
subject to adjustment in accordance with the anti-dilution and transactional
adjustment provisions described below. Each warrant holder will be able to
exercise the warrants, in whole or in part, by delivering to us the certificate
representing the warrants, the exercise notice properly completed and executed
and payment of the aggregate exercise price for the number of shares of our
common stock as to which the warrant is being exercised. The exercise price is
payable in cash or by check payable to the order of Vishay Intertechnology,
Inc., except upon exercise of the warrants in an underwritten public offering or
in a block trade (see "Transfer and Exercise of Warrants" below).

We will not issue any fractional shares of our common stock upon the
exercise of the warrants. We will pay a cash adjustment instead of fractional
shares equal to the product resulting from multiplying the fractional amount by
the daily market value of one share of our common stock on the trading day prior
to the date the warrant is exercised.

Upon exercise of any warrant, we will deliver a stock certificate
representing the number of shares that were exercised under the warrant. If the
warrant is not fully exercised, we will execute a new warrant certificate
exercisable for the remaining shares and deliver the new warrant certificate at
the same time as the stock certificate for the exercised shares.

Adjustments

The exercise price of the warrants and the number of shares of our common
stock purchasable upon the exercise of the warrants is subject to adjustment in
certain situations.

In the description of the adjustments that follows, we use the following
terms and concepts:

The Black-Scholes value of the warrants is to be determined on the basis
of the Black-Scholes methodology by an investment banking firm of national
reputation and standing, selected by us and reasonably acceptable to a majority
of the warrant holders, but the Black-Scholes Value of a warrant cannot exceed
the daily market price of our common stock on the day immediately preceding the
transaction in question. For purposes of applying the Black-Scholes methodology,
the price per share of our common stock is deemed to be the average of the daily
market prices for the ten full trading days ending ten trading days prior to the
first public announcement of the relevant transaction, and the methodology is to
be applied as if the relevant transaction had not occurred.

Daily market price. Daily market price means, for any trading day, the
volume-weighted average of the per share selling prices on that trading day of
our common stock or other relevant security on the principal market on which the
relevant security is then quoted. If there are no sales of the security on the
trading day, daily market price means the average of the high bid and low ask
price for the relevant security on the last trading day on which a sale was
reported. If the security is not traded so that there are no bid and ask prices,
the daily market price will be the per share fair market value of the relevant
security as determined by an investment banking firm of national reputation and
standing that we select and that is reasonably acceptable to a majority of the
warrant holders.

Majority of the warrant holders means, at any time, the holders of
warrants that are exercisable for more than 50% of the shares for which all
outstanding warrants are exercisable at that time. Whenever reasonable approval
of a majority of the warrant holders is required for any action or
determination, that approval is deemed to be given if a majority of the warrant
holders do not reasonably object to the action or determination by written
notice to us within ten business days of the date on which notice of the action
or determination is first given to the holders.

Declaration of Stock Dividend, Splits, Reverse Splits or Reclassification
or Reorganization; Other Distributions. We will make the following adjustments
if we declare a stock dividend, split, reverse split, if there is a
reclassification or reorganization of our common stock or if we make
distributions on our common stock. In each case, we will issue a notice to each
warrant holder at least ten business days before the record date of the
adjustment. Any adjustment will become effective immediately after the effective
date of the adjustment retroactive to the record date, if any.

If we declare any dividend or other distribution payable in shares of
common stock or subdivide the outstanding shares of our common stock into a
greater number of shares, then the exercise price per share of the warrants will
be decreased proportionately, and the number of shares of our common stock
issuable upon exercise of the warrant will be increased proportionately.

If we combine the outstanding shares of our common stock into a smaller
number of shares, then the exercise price per share of the warrants will be
increased proportionately, and the number of shares of our common stock issuable
upon exercise of the warrants will be decreased proportionately.

If we issue to holders of our shares of common stock any indebtedness,
shares of our stock or any other securities by reclassification of our common
stock; distribute to holders of our shares of common stock any rights, options
or warrants to purchase or subscribe for any evidence of indebtedness, shares of
our stock (other than distributions in connection with adjustments for issuances
of any rights, options or warrants, or spin-offs) or any other securities;
distribute to holders of our shares of common stock cash (other than regular
quarterly or semi-annual cash dividends) or other property; or issue by means of
a capital reorganization our other securities in lieu of our common stock or in
addition to our common stock, then the warrants will be adjusted so that each
warrant will be exercisable into the kind and number of our shares or other
securities or securities of any successor entity, or cash or other property that
the warrant holder would have owned or have been entitled to receive had the
warrant holder exercised the warrants immediately prior to any of these events.

Rights Issuance. We will make the following adjustments if we distribute
any rights, options or warrants to holders of our common stock:

o If we distribute any rights, options or warrants to holders of our
common stock entitling them, for a period of 60 days or less after the
record date for determination of the stockholders entitled to receive
these rights, to purchase or subscribe for shares of our common stock
at a price per share less than 90% of the daily market price of our
common stock on the record date, then we will increase the number of
shares issuable upon exercise of the warrants in the proportion that

o the maximum number of shares issuable upon exercise of the
warrants plus the number of outstanding shares, bears to

o the maximum number of shares that would have been issuable upon
exercise price of the warrants had their exercise price been the
average market price for Vishay common stock over a specified
trading period plus the number of outstanding shares.

The adjustment will be made in accordance with the following formula:

N = No x (O + A)/ (O +C/M))

where:

N = the adjusted number of shares issuable upon exercise of a
warrant;

No = the number of shares issuable upon exercise of a warrant prior
to the adjustment;

O = the number of shares outstanding immediately prior to the
issuance of the rights, options or warrants;

A = the maximum number of shares issuable pursuant to the rights,
options or warrants;

C = the aggregate consideration that we will receive for the issuance
of our common stock upon exercise of the rights, options or
warrants; and

M = the average of the daily market prices of our common stock for
the ten consecutive trading days immediately preceding the record
date.

The exercise price of the warrants will be correspondingly reduced. If
less than all of the rights, options or warrants have been exercised upon the
expiration of such rights, options or warrants, the number of shares issuable
upon exercise of the warrants and corresponding adjustment to the exercise price
of the warrants will be readjusted based on the number of rights, options or
warrants actually exercised.

If we distribute any rights, options or warrants to holders of our common
stock entitling them, for a period of more than 60 days after the record date,
to purchase or subscribe for shares of our common stock at a price per share
less than 90% of the daily market price of our common stock on the record date,
then we will distribute the same rights, options or warrants to the warrant
holders on the record date as if the warrant holders had exercised their
warrants immediately prior to the record date.

Liquidation or Dissolution. If we liquidate, dissolve or wind up our
affairs, other than in connection with a consolidation, merger or sale or
conveyance of all or substantially all of our assets or a spin-off transaction,
then the warrants will terminate and expire at the close of business on the last
full business day before the earliest record date fixed for the payment of any
distributable amount on our common stock. At least ten business days prior to
the record date, we will provide each warrant holder with notice of the
liquidation, dissolution or winding up of affairs. Upon exercise of the
warrants, each warrant holder will receive consideration in the liquidation on
the same basis as holders of our common stock or other securities of any other
class for which the warrants are then exercisable.

Merger or Consolidation. If any person or entity acquires us in a
transaction in which we are merged with or into or consolidated with another
person or entity, or if we sell or convey all or substantially all of our assets
to another person or entity, then we will make the adjustments described below.
In each case, we will give written notice to each warrant holder of any change
at least ten business days prior to the effective date of the change. These
provisions do not apply to a transaction in which we are the surviving entity
and have reporting obligations under the Securities Exchange Act because of the
registration of our equity securities.

The warrant holder will receive, at the holder's election, either:

o upon exercise of the warrants, including the payment of the exercise
price therefor, the kind and number of shares, securities, cash, assets
or other property which the holder would otherwise have been entitled
to receive in the transaction had the holder exercised the warrants
before the transaction, or

o the Black-Scholes value of the warrants in cash, or in certain
circumstances, in securities of the purchaser. This cash-out option may
not be available in certain circumstances if it would interfere with
the tax or accounting treatment of the transaction.

If the acquirer is a reporting company under the Securities Exchange Act,
and the acquirer is offering a combination of cash and shares, then the warrant
holder may elect to receive a combination of:

o a warrant exercisable for securities of the acquirer in an amount and
at an exercise price described below, but otherwise having the same
terms as the Vishay warrants, and

o a cash amount calculated as described below.

The exercise price for the acquirer warrants will be the exercise price
for the Vishay warrants multiplied by the ratio of the market value of a share
of our common stock averaged over a specified trading period to the market price
of share of acquirer stock averaged over the same period. The formula for
determining the exercise price of the acquirer warrants is as follows:

Ea = (Eo x (Pa/Pt))

where:

Ea = the per share exercise price of the acquirer warrants;

Eo = the per share exercise price of the Vishay warrants;

Pt = the average of the daily market prices of our common stock for
the ten consecutive trading days immediately preceding the
effective date of the transaction; and

Pa = the average daily market price of the acquirer shares for the ten
consecutive trading days immediately preceding the effective date
of the transaction.

The number of acquirer shares issuable upon exercise of an acquirer
warrant will be the number of shares exercisable upon exercise of the Vishay
warrant multiplied by the number of acquirer shares delivered for each Vishay
share in the transaction. The formula for determining this number is as follows:

Na = a x No
where:

Na = the number of shares issuable upon exercise of the acquirer
warrant;

a = the number of acquirer shares delivered in the transaction to
holders of our common stock for each share of our common
stock; and

No = the number of shares issuable upon exercise of the original
Vishay warrant;

The amount of cash (or in certain circumstances the value of securities of
the acquirer) will be determined by multiplying the Black-Scholes value of the
Vishay warrant by the fraction of the total value of the consideration payable
to Vishay stockholders in the transaction attributable to the cash that they
receive. The formula for this determination is as follows:

AC = BSw x (1-((a x Pa) /C ))

where the symbols defined above have the same meanings here and:

AC = the cash amount;

BSw = the Black-Scholes value of the Vishay warrant; and

C = the total fair market value of the consideration delivered in
the transaction to holders of our common stock for each share
of our common stock. For purposes of determining this amount:

o the fair market value of the component of the
consideration consisting of shares of the acquirer is
deemed to be the average daily market price of the
acquirer shares for the ten consecutive trading days
immediately preceding the effective date of the
transaction multiplied by the number of acquirer shares
delivered in the transaction for each share of our
common stock;

o the fair market value of any cash component is the
amount of the cash delivered in the transaction for each
share of our common stock; and

o the fair market value of any other consideration
delivered in the transaction for each share of our
common stock will be as determined by an investment
banking firm of national reputation and standing
selected by us and reasonably acceptable to a majority
of the warrant holders.

This cash-out election may not be available in certain circumstances if it
would interfere with the tax or accounting treatment of the transaction. Under
these circumstances, a warrant holder may elect to receive shares of the
acquirer having a fair market value (determined as described above) equal to the
cash amount, provided this would not interfere with the tax or accounting
treatment of the transaction.

We will give the warrant holders notice of any transaction to which this
discussion relates at least ten business days prior to the effective date of the
transaction and earlier in certain circumstances.

Spin-offs. We refer to a distribution to all holders of our common stock
consisting of the capital stock of one of our subsidiaries or other business
units as a spin-off. If a spin-off were to occur, each holder of a warrant on
the date of the spin-off distribution will be entitled to receive a warrant to
purchase the number of shares of capital stock of the spin-off company that the
holder would have received had the holder exercised the warrant immediately
prior to the record date for the spin-off. The terms of the spin-off warrants
will be the same as the Vishay warrants, except that the exercise price of the
spin-off warrant will be determined by multiplying the exercise price of the
Vishay warrant by the ratio of the market value of a spin-off share, averaged
over a specified period following the spin-off, to the combined value of Vishay
shares and spin-off shares, averaged over the same period, that Vishay
stockholders will hold following the spin-off for each share of Vishay stock
that they held prior to the spin-off. The formula for this determination is as
follows:

Es = Eo x Ps / (Pp+ (r x Ps))

where:

Es = the per share exercise price of the spin-off warrants;

Eo = the per share exercise price of the Vishay warrants;

r = the number of spin-off shares, which may be one or a fraction
less than or greater than one, distributed in the spin-off in
respect of each share of our common stock; and

Ps = the average daily market price of the spin-off shares for the ten
consecutive trading days following the date of the spin-off. If,
however, the spin-off shares do not begin trading within two
trading days after the date of the spin-off or do not trade for
at least ten consecutive trading days within 20 days after the
spin-off, then this quantity will mean the per share fair market
value of the spin-off shares as of the date of the spin-off,
determined by an investment banking firm of national reputation
and standing selected by us and reasonably acceptable to a
majority of the warrant holders on the record date for the
spin-off.

Pp = the average of the daily market prices of our common stock for
the ten consecutive trading days following the date on which the
spin-off is consummated;

Following the spin-off, the exercise price of each Vishay warrant will be
adjusted by multiplying the exercise price by the ratio of the market value of a
share of Vishay stock, averaged over a specified period following the spin-off,
to the combined value of Vishay shares and spin-off shares, averaged over the
same period, that Vishay stockholders will hold following the spin-off for each
share of Vishay stock that they held prior to the spin-off. The formula for this
adjustment is as follows:

En = Eo x Pp / (Pp+ (r x Ps))

where:

En = the adjusted exercise price of the warrants per share of our
common stock,

with the other symbols in the formula having the meanings specified in
the preceding formula.

If distribution of spin-off shares to the warrant holders would, in the
reasonable opinion of our counsel, prevent the tax-free nature of the spin-off
or require us to register the spin-off with the SEC when we would not otherwise
be required to do so, then the warrant holders will not receive warrants in the
spin-off company. Instead, the number of shares issuable upon exercise of a
Vishay warrant will be increased by the ratio of the combined value of Vishay
shares and spin-off shares, averaged over a specified period following the
spin-off, that Vishay stockholders will hold following the spin-off for each
share of Vishay stock that they held prior to the spin-off to the market value
of a Vishay share, averaged over the same period. The formula for this increase
is as follows:

Nn = No x (Pp + (r x Ps))/Pp

where:

Nn = the adjusted number of shares issuable upon exercise of a
warrant; and

No = the number of shares issuable upon exercise of the warrant
prior to adjustment,

with the other symbols in the formula having the meanings specified in the
second preceding formula.

In this case, the exercise price of the warrants will be decreased by the
ratio of the number of shares of Vishay stock issuable upon exercise of a
warrant prior to the spin-off to the number of Vishay shares issuable upon
exercise following the spin-off. The formula for this decrease is as follows:

En = Eo x (No/Nn)
where:

En = the adjusted exercise price of the warrants per share of our
common stock; and

Eo = the exercise price per share of our common stock of the warrants
immediately prior to adjustment for the spin-off,

with the other symbols in the formula having the meanings specified in
the preceding formula.

We will give the warrant holders notice of any spin-off at least ten
business days prior to the record date for the spin-off.

Warrant Agent

We have appointed our transfer agent, American Stock Transfer & Trust Co.,
to serve as warrant agent. The warrant agent will issue, transfer and exchange
the certificates for the warrants. Upon exercise of the warrants by the warrant
holders, the warrant agent will notify us to issue or cause to be issued the
certificates representing the appropriate number of shares of our common stock
or other consideration issuable upon exercise of those warrants.

We have agreed to pay the warrant agent reasonable compensation for its
services and to reimburse us for its reasonable expenses. We have also agreed to
indemnify the warrant agent from all damages arising in connection with the
warrant agent's execution of its duties and powers under the warrant agreement,
except for any damages arising as a result of the warrant agent's gross
negligence or willful misconduct.

The warrant agent may resign upon 30 days' prior written notice. At least
15 days before the effective date of the resignation, the warrant agent will, at
our expense, cause to be mailed a copy of its notice of resignation to each
warrant holder. Upon the resignation of the warrant agent, we may, in our sole
discretion, appoint a new warrant agent. If we do not appoint a new warrant
agent within 30 days after we have been notified in writing of the former
warrant agent's resignation, then any warrant holder may apply to a court for
the appointment of a new warrant agent. Each new warrant agent will have the
same powers, rights, duties and responsibilities as if it had been originally
named as the warrant agent.

Warrant Holder Not a Stockholder

Neither the warrant agreement nor any of the warrants entitles any warrant
holder to any voting or other rights of a holder of shares of our common stock.

Transfer and Exercise of Warrants

Each warrant may be presented for transfer at any time on or prior to its
expiration date, after which date each warrant will become wholly void and of no
value. Any proposed transfer of the warrants must be made pursuant either to an
exemption from the registration requirements of the Securities Act or to an
effective registration statement. In addition, each transfer must be made in
accordance with the applicable securities laws of any state of the United States
or any other applicable jurisdiction.

Prior to any transfer, a warrant holder must deliver written notice to us
and to the warrant agent of his, her or its intention to transfer the warrants.
If the transfer of the warrants is being made pursuant to an exemption from the
registration requirements of the Securities Act, then we may also require that
the warrant holder deliver to us an agreement by the transferee to be bound by
certain restrictions on transfer set forth in the warrant agreement. We may also
require an opinion of counsel that the transfer complies with applicable
securities laws.

The warrant agent will register all transfers of outstanding warrant
certificates in the warrant register. Upon registration of the transfer, the
warrant agent will issue a new warrant certificate to the transferee and cancel
the surrendered warrant certificate.

If any warrant holder sells shares of our common stock issuable upon
exercise of the warrants in an underwritten public offering, then we will
cooperate with the warrant holders and the underwriters to ensure that the
warrants may be exercised and the underlying shares of common stock delivered to
the underwriters for sale in the offering. Upon consummation of the offering,
the underwriters will deliver the exercise price of the warrants to us.

If any initial warrant holder or its affiliates sells shares of our common
stock issuable upon exercise of the warrants in a "block trade", then we will
cooperate with the warrant holders and the broker in the trade so that the
warrants may be exercised and the underlying shares of common stock delivered to
the broker. Upon consummation of the trade, the broker will deliver the exercise
price of the warrants to us. A block trade means the disposition at a single
time in a single transaction by one or more initial holders of not less than
1,000,000 warrant shares in the aggregate to one or more "institutional
investors" or purchasers procured by a broker on behalf of such initial holders.
This number of warrant shares is subject to adjustments for stock splits,
reverse stock splits and similar transactions. An institutional investor means,
for purposes of the warrant agreement, any insurance company, pension fund,
mutual fund, investment company, commercial bank or investment bank, or any
portfolio managed by any of these entities.

REGISTRATION RIGHTS

The following description of the registration rights sets forth a summary
of the terms and provisions of the registration rights relating to the warrants
and the shares of our common stock issuable upon exercise of the warrants and
exchange of the notes, provided in a securities investment and registration
rights agreement that we have executed. The summary does not purport to be
complete and is qualified in all respects by reference to the actual text of the
securities investment and registration rights agreement, a copy of which has
been filed as an exhibit to the registration statement of which this prospectus
is a part. We urge you to read the text of the securities investment and
registration rights agreement because that document, and not this description,
defines your complete registration rights as a warrant holder or a note holder.

Under the securities investment and registration rights agreement, we
agreed to file at our expense, no later than 30 days after the closing date of
our issuance of the warrants and the notes, a shelf registration statement
covering:

o resales of the warrants;

o resales of the shares of our common stock issuable upon exchange of
the notes;

o resales of the shares of our common stock issuable upon exercise of
the warrants, but only by the initial holders of the warrants or their
affiliates or in an underwritten public offering; and

o our sale of the shares of our common stock issuable upon exercise of
the warrants.

In addition, if for any reason we cannot register our sale of the shares
issuable upon exercise of the warrants, we are obligated to register those
shares for resale by the holders of those shares.

This prospectus is part of a registration statement that we filed to meet
our obligations under the registration rights agreement.

We are required to use our reasonable best efforts to cause the
registration statement to be declared effective under the Securities Act by the
date that is 180 days after the date of our issuance of the warrants and the
notes. However, we have not been able to meet this deadline. Upon effectiveness
of the registration statement, we will have no further obligation to register
securities under the registration rights agreement, unless we effect a spin-off.
If a spin-off were to occur and holders received warrants or notes of the
spin-off entity, we would be required to cause the spin-off entity to register
its securities in a manner similar to the registration of the Vishay securities
under the registration statement. In addition, we are required to use our
reasonable best efforts to maintain the effectiveness of the registration
statement:

o in the case of the securities registered for resale, until four months
after the tenth anniversary of our issuance of the warrants and the
notes, or, if earlier, until there are no outstanding resale
securities; and

o in the case of the registration of the shares issuable upon exercise
of the warrants, until the tenth anniversary of the date the warrants
were issued or, if earlier, until all of the warrants have been
exercised.

Underwritten Public Offerings. We granted rights to effect the disposition
of shares of our common stock issuable upon exercise of the warrants or exchange
of the notes in an underwritten public offering.

On demand of the holders, we are required to effect up to two underwritten
public offerings of the shares of our common stock issuable upon exercise of the
warrants. We are not required to effect more than one of these offerings in any
12-month period or unless the aggregate size of the offering is at least
3,000,000 shares. This number is subject to adjustment for stock splits, reverse
splits and similar transactions. Further, in the case of an underwritten public
offering in which the warrants will be exercised in connection with the
offering, we are not required to effect an underwritten offering unless the per
share price of our common stock exceeds a minimum price. This minimum price is
the lesser of $1.00 more than the then exercise price of the applicable warrants
and five percent more than the exercise price of the applicable warrants. This
price must be exceeded on each of 20 trading days in any 30 trading day period,
and the warrant holders making the demand for the underwritten offering must
provide us with written notice of the demand no later than five business days
following this 30-day trading period.

Similarly, on demand of the holders, we are required to effect up to two
underwritten public offerings of the shares of our common stock issued or
issuable upon exchange of the notes. We are not required to effect more than one
of these offerings in any 12-month period or unless the aggregate size of the
offering is at least 3,000,000 shares. This number is subject to adjustment for
stock splits, reverse splits and similar transactions.

If we effect a spin-off and warrants and notes of the spin-off company are
distributed to the warrant holders and the note holders in partial substitution
of the warrants and the notes, we are required to cause the spin-off company, on
demand, to effect underwritten public offerings of the common stock issued or
issuable on exercise of the spin-off warrants and the spin-off notes. The
spin-off company will not be obligated to effect more than four of these
underwritten offerings in total, of which the holders of spin-off warrants and
the holders of spin-off notes will each be entitled to two of these offerings.
The spin-off company will not required to effect more than one of each of these
offerings in any 12-month period or unless the offering will result in gross
proceeds of not less than $30,000,000.

If we propose to register any of our securities under the Securities Act,
either for our account or for the account of other securityholders, for sale in
an underwritten public offering, we will give each holder of shares of our
common stock issuable upon exercise of the warrants and exchange of the notes
notice of the registration. We will include in the registration statement and
the underwritten offering the shares issued or issuable on exercise of the
warrants or issued or issuable on exchange of the notes of holders that request
inclusion. The right of the holders to participate in such an offering does not
apply to an underwritten offering made pursuant to a draw down off of a shelf
registration statement. Also, this right of participation is subject to
customary cutbacks if the managing underwriters for the offering advise us that
the size of the proposed public offering is sufficiently large to materially
adversely affect the success of the proposed offering.

We also have the right to include securities sold for our benefit in an
underwritten public offering effected on demand of the warrant holders or the
note holders. This right of participation is subject to customary cutbacks if
the managing underwriters for the offering advise us that the size of the
proposed public offering is sufficiently large to materially adversely affect
the success of such proposed offering.

Deferral and Holdback Events. We will be permitted to suspend the filing
of any registration statement and/or to request that the holders refrain from
effecting any public sales or distributions of securities under a registration
statement that we file in accordance with the securities investment and
registration rights agreement for a period not to exceed 45 consecutive days or
an aggregate of 90 days during any 12-month period. We are entitled to require
this suspension under circumstances in which our board of directors determines
that the registration of the securities or the disclosure of a material event or
transaction required to be disclosed would have a material adverse effect on our
business, assets, condition results of operations or prospects or would
jeopardize the success of the transaction.

If we effect a public underwritten offering for the sale of shares for our
benefit or for the benefit of the another securityholder and the managing
underwriters for the offering so require, the holders will be prohibited from
effecting any public sale or distribution of our securities, except as part of
the offering, during the period beginning seven days prior to the closing date
of the offering and ending on the earlier of 90 days after the closing date and
the date such sale or distribution is permitted by the managing underwriter or
underwriters. This limitation will not apply to any holder who, together with
its affiliates and any person with whom it is acting together, beneficially owns
less than 2% of our outstanding common stock.

General. We will give notice of the effectiveness of the registration
statement to all holders who have provided us with a selling securityholder
notice and questionnaire. Each holder must complete the notice and questionnaire
at least five business days before the effective date of the registration
statement in order to be named as a selling securityholder in this prospectus.
If we receive completed questionnaires from holders after the effectiveness of
the registration statement, we will, as promptly as practicable, file amendments
or supplements to the registration statement naming those holders as selling
securityholders, thereby allowing them to sell their securities under the
registration statement.

We will pay all registration expenses, except that the selling
securityholders will pay all underwriting discounts, commissions or fees
attributable to their resale of securities under the registration statement.

The selling securityholders and we have agreed to indemnify each other and
our respective controlling persons against, and in certain circumstances to
provide contribution with respect to, specific liabilities in connection with
the offer and sale of the warrants and the common stock underlying the notes and
the warrants under the registration statement, including liabilities under the
Securities Act.

CERTAIN UNITED STATES FEDERAL TAX CONSEQUENCES

The following discussion sets forth the material U.S. federal income tax
consequences to holders, and U.S. estate tax consequences to non-U.S. Holders
(defined below), relating to the ownership, exercise and disposition of Vishay
common stock and the warrants described herein to purchase Vishay common stock.
The discussion constitutes the opinion of Kramer Levin Naftalis & Frankel LLP,
subject to the qualifications set forth in the opinion letter provided by Kramer
Levin to Vishay, which is filed as an exhibit to the registration statement of
which this prospectus is a part. The discussion which follows is based on the
U.S. Internal Revenue Code of 1986, as amended, Treasury Regulations promulgated
thereunder, administrative rulings and pronouncements and judicial decisions as
of the date hereof, all of which are subject to change, possibly with
retroactive effect. Any such change could alter the tax consequences discussed
in this document. No ruling has been sought from the Internal Revenue Service
with respect to the federal tax consequences discussed in this prospectus, and
there can be no assurance that the IRS or a court will not take a position
contrary to the federal tax consequences discussed herein or that any contrary
position taken by the IRS or a court would not be sustained.

The discussion below does not address the effects of any state, local or
non-U.S. tax laws. In addition, the discussion below relates to persons who hold
Vishay common stock and warrants to purchase Vishay common stock as capital
assets. The tax treatment of a holder may vary depending upon the holder's
particular situation, and certain holders may be subject to special rules not
discussed below, including for example, partners of entities classified as
partnerships for U.S. federal income tax purposes that hold Vishay common stock
and/or warrants, persons who hold Vishay common stock and/or warrants through
entities which are disregarded for U.S. federal income tax purposes, regulated
investment companies, insurance companies, tax-exempt organizations, U.S.
expatriates, financial institutions, dealers in securities or foreign
currencies, or holders who hold our common stock and/or warrants as part of a
"straddle," "hedge," conversion, constructive sale or another integrated
transaction for tax purposes, or U.S. Holders, as defined below, whose
functional currency is not the U.S. dollar.

Investors considering the purchase of common stock and/or warrants should
consult their own tax advisors with respect to the application of the U.S.
federal income and estate tax laws to their particular situations as well as any
tax consequences arising under the laws of any state, local or foreign taxing
jurisdiction or under any applicable tax treaty.

As used in this section, a "U.S. Holder" means a beneficial owner of
Vishay common stock and/or warrants that is, for U.S. federal income tax
purposes:

o a citizen or resident of the U.S.;

o a corporation or an entity treated as a corporation for U.S. federal
income tax purposes created or organized in or under the laws of the
U.S. or any political subdivision thereof;

o an estate whose income is subject to U.S. federal income tax
regardless of its source; or

o a trust if (i) in general, a court within the U.S. is able to exercise
primary supervision over its administration and one or more U.S.
persons have authority to control all substantial decisions of the
trust or (ii) it has a valid election in effect under applicable U.S.
treasury regulations to be treated as a U.S. person.

As used in this section, a non-U.S. Holder is a beneficial owner of
Vishay common stock and/or warrants that is not a U.S. Holder.

For U.S. federal income tax purposes, income earned through a
partnership or an entity treated as such for U.S. federal income tax purposes
generally is attributed to its owners.

U.S. Holders

Warrants

A U.S. Holder that exercises his, her or its warrants should not recognize
income, gain or loss for U.S. federal income tax purposes as a result of such
exercise, except that any cash paid in lieu of issuing fractional shares will be
treated as received in exchange for an applicable number of warrant(s) or
fraction thereof and the holder will recognize gain or loss on such exchange in
the manner discussed below. A U.S. Holder's tax basis in common stock acquired
upon exercise of his, her or its warrants should equal such holder's tax basis
in his, her or its exercised warrants (which, in the case of initial holders of
warrants, in general should equal their fair market value on the date of
issuance to the initial U.S. Holder) plus the exercise price paid for such
stock. The holding period for the common stock acquired upon exercise of
warrants should begin on the date the warrants are exercised. If a U.S. Holder's
warrants expire unexercised, the holder should have a capital loss equal to his,
her or its tax basis in its unexercised warrants. The deductibility of capital
losses, if any, realized on the expiration of unexercised warrants may be
subject to certain limitations.

Upon the sale, exchange or other taxable disposition of warrants, a U.S.
Holder generally will recognize capital gain or loss equal to the difference
between (i) the amount of cash and the fair market value of any property
received upon the disposition and (ii) the U.S. holder's adjusted tax basis in
the warrants. Such gain or loss will be long-term if the U.S. Holder's holding
period is more than one year. Under recently enacted legislation, long-term
capital gains recognized by non-corporate U.S. Holders will be taxed at a
maximum rate of 15% through 2008.

The exercise price of the warrants may be adjusted under certain
circumstances. Section 305 of the Code treats certain actual or constructive
distributions of stock with respect to stock or convertible securities as a
distribution taxable as a dividend (to the extent of the issuer's current and
accumulated earnings and profits as of the end of the taxable year in which the
distribution occurs). Under applicable Treasury regulations, an adjustment to
the exercise price of warrants may, under certain circumstances, be treated as a
constructive dividend under these rules to the extent it increases the
proportional interest of a U.S. Holder in Vishay's fully diluted common stock,
whether or not the holder ever exercises the warrants into common stock.
Generally, a holder's tax basis in a warrant will be increased by the amount of
any constructive dividend. Similarly, a failure to adjust the conversion price
of the warrants to reflect a stock dividend or similar event could in some
circumstances give rise to constructive dividend income to holders of common
stock.

Stock

If Vishay makes distributions on its common stock, those distributions
generally will be treated as a dividend, subject to tax as ordinary income, to
the extent of Vishay's current and accumulated earnings and profits as of the
end of its taxable year in which the distribution occurs. Any excess will be
treated as a tax-free return of capital to the extent of the U.S. Holder's
adjusted tax basis in the common stock and thereafter as gain from the sale or
exchange of that stock. Subject to applicable rules, U.S. Holders that are
corporations may be eligible to claim a deduction equal to a portion of any
distributions received treated as dividends. Under recently enacted legislation,
dividends and long-term capital gains recognized by non-corporate U.S. Holders
will be taxed at a maximum rate of 15% through 2008.

Upon the sale, exchange or other taxable disposition of Vishay common
stock, a U.S. Holder generally will recognize capital gain or loss equal to the
difference between (i) the amount of cash and the fair market value of any
property received upon the disposition and (ii) the U.S. Holder's adjusted tax
basis in the common stock or warrants, as applicable. Such gain or loss will be
long-term if the U.S. Holder's holding period is more than one year.

Non- U.S. Holders

For purposes of the following discussion, dividends on Vishay common stock
and gain from the sale or other disposition of Vishay common stock and/or
warrants will be considered to be "U.S. trade or business income" if such income
or gain is (i) effectively connected with the conduct of a U.S. trade or
business and (ii) in the case of a treaty resident, attributable to a permanent
establishment in the United States.

Warrants

A non-U.S. Holder that exercises his, her or its warrants should not
recognize income, gain or loss for U.S. federal income tax purposes as a result
of such exercise (except that any cash paid in lieu of issuing fractional shares
will be treated as received in exchange for an applicable number of warrant(s)
or fraction thereof). A non-U.S. Holder generally will not be subject to U.S.
federal income tax on any gain from the sale, exchange or other disposition of
warrants, other than in those instances set forth below in which a non-U.S.
Holder would be subject to tax upon the sale or disposition of common stock. See
"Non-U.S. Holders--Stock" below. A non-U.S. Holder's bases and holding periods
in the warrants and in common stock received upon exercise of the warrants are
computed in the same manner as a U.S. Holder would compute such items. See "U.S.
Holders--Warrants" above.

As discussed above, an adjustment to the exercise price of the warrants
could potentially give rise to a deemed distribution to holders of the warrants.
See "U.S. Holders--Warrants" above. With respect to non-U.S. Holders, the deemed
distribution would be subject to the rules below regarding withholding of U.S.
federal tax on dividends in respect of common stock. See "Non-U.S.
Holders--Stock" below.

Stock

If Vishay makes distributions on its common stock, such distributions will
constitute dividends for U.S. federal income tax purposes to the extent of its
current and accumulated earnings and profits, as determined for U.S. federal
income tax purposes, as of the end of its taxable year in which the distribution
occurs.

In general, dividends paid to a non-U.S. Holder that are not U.S. trade or
business income will be subject to withholding of U.S. federal income tax at a
30% rate unless such rate is reduced by an applicable income tax treaty. In
order to obtain a reduced rate of withholding under an income tax treaty, a
non-U.S. Holder generally will be required to provide a properly completed and
executed IRS Form W-8 BEN (or successor form) to Vishay or its paying agent, or
similar appropriate documentation or substitute form, certifying the non-U.S.
Holder's entitlement to benefits under an applicable income tax treaty. A
non-U.S. Holder that is eligible for a reduced rate of U.S. withholding tax
pursuant to an income tax treaty generally may obtain a refund of any excess
amounts withheld by filing an appropriate claim for a refund with the IRS.

Dividends that are U.S. trade or business income generally will not be
subject to withholding of U.S. federal income tax if the non-U.S. Holder
provides a properly completed and executed IRS Form W-8ECI (or successor form)
to Vishay or its paying agent, or similar appropriate documentation or
substitute form, certifying that the dividends are U.S. trade or business
income. Instead, dividends that are U.S. trade or business income generally will
be subject to U.S. federal income tax on a net income basis at the regular
graduated U.S. federal income tax rates. Any dividends that are U.S. trade or
business income received by a non-U.S. Holder that is a corporation may also,
under certain circumstances, be subject to an additional "branch profits tax" at
a 30% rate or such lower rate as may be specified by an applicable income tax
treaty.

A non-U.S. Holder generally will not be subject to U.S. federal income
tax on the sale or other disposition of common stock unless:

o such gain is U.S. trade or business income, in which case the non-U.S.
Holder would be taxed on the net gain derived from the sale or other
disposition under the regular graduated U.S. federal income tax rates.
In addition, a non-U.S. Holder that is a corporation may be subject to
an additional "branch profits tax" at a rate of 30% or a lower rate as
may be specified by an applicable income tax treaty;

o the non-U.S. Holder is a non-resident alien individual who holds the
common stock as a capital asset, is present in the United States for
183 days or more during the taxable year of the disposition, and
certain other conditions are present, in which case such non-U.S.
Holder generally will be subject to a flat 30% tax on the gain derived
from the sale or other disposition of the common stock; or

o Vishay is or has been a "United States real property holding
corporation" within the meaning of Section 897(c)(2) of the Code at
any time during the shorter of the five-year period ending on the date
of the sale or other disposition of the common stock or the period
during which the non-U.S. Holder has held the common stock.

Vishay believes that it has not been, is not currently, and is not likely
to become in the future, a "United States real property holding corporation"
within the meaning of Section 897(c)(2) of the Code. However, no assurance can
be given that Vishay will not be a "United States real property holding
corporation" when a non-U.S. Holder sells his, her or its shares of common
stock. If Vishay were to become a "United States real property holding
corporation," a non-U.S. Holder would still not be subject to U.S. federal
income tax on the sale or other disposition of the common stock if the shares of
common stock are considered to be "regularly traded on an established securities
market" within the meaning of Section 897(c)(3) of the Code and the non-U.S.
Holder does not own, actually or constructively, at any time during the shorter
of the periods described above, more than five percent of the outstanding shares
of Vishay's common stock.

Federal Estate Tax

Vishay common stock or warrants owned or treated as owned by an individual
who is not a citizen or resident of the United States for U.S. federal estate
tax purposes at the time of death (or Vishay common stock or warrants previously
held by such an individual who transferred the stock or warrants subject to
certain retained rights or powers) will be included in the individual's gross
estate for U.S. federal estate tax purposes, and may be subject to U.S. federal
estate tax, unless otherwise provided by an applicable estate tax treaty.

Backup Withholding and Information Reporting

Non-exempt U.S. Holders may be subject to information reporting with
respect to payments of proceeds from the disposition of Vishay common stock and
dividends on Vishay common stock. Non-exempt U.S. Holders who are subject to
information reporting and who do not provide appropriate information when
requested may be subject to backup withholding. U.S. Holders should consult
their tax advisors.

Vishay must report annually to the IRS and to each non-U.S. Holder any
dividend income that is subject to withholding, or that is exempt from U.S.
withholding tax pursuant to a tax treaty. Copies of these information returns
may also be made available, under the provisions of a specific treaty or
agreement, to the tax authorities of the country in which the non-U.S. Holder
resides. In general, backup withholding will not apply to dividends on common
stock made by Vishay or its paying agent, in its capacity as such, to a non-U.S.
Holder if the holder has provided the required certification that it is not a
U.S. person. If a non-U.S. Holder fails to provide the required certification,
distributions on common stock may be subject to backup withholding in certain
circumstances.

In general, backup withholding and information reporting will not apply to
the proceeds from the disposition of common stock paid to a non-U.S. Holder if
the holder has provided the required certification that it is not a U.S. person.
If a non-U.S. Holder fails to provide the required certification, proceeds from
the disposition of common stock may be subject to backup withholding and
information reporting in certain circumstances.

Backup withholding is not an additional tax. Any amounts withheld under
the backup withholding rules from a payment to any holder will be allowed as a
refund or a credit against such holder's U.S. federal income tax liability
provided the requisite procedures are followed.

SELLING SECURITYHOLDERS

The selling securityholders, including their transferees, pledgees, donees
or successors may, from time to time, offer and sell the warrants or the common
stock issuable upon exchange of the notes pursuant to this prospectus. In
addition, the initial holders of the warrants and their affiliates may sell
shares issuable upon exercise of the warrants pursuant to this prospectus, and
all holders of warrants may sell shares issuable upon exercise of the warrants
pursuant to this prospectus in an underwritten public offering, if the exercise
is in connection with the sale of the shares, or as otherwise provided in this
prospectus. Our registration of the warrants and the common stock underlying the
notes and the warrants does not necessarily mean that the selling
securityholders will sell all or any of these securities.

The following table sets forth certain information as of February 20,
2004, concerning the warrants and common stock of the selling securityholders.

We have assumed for purposes of the table below that the selling
securityholders will exchange all of the notes and exercise all of the warrants
owned and being offered under this prospectus. We have also assumed that the
selling securityholders will sell all of the note exchange shares and warrant
shares. The selling securityholders identified below may have sold, transferred
or otherwise disposed of all or a portion of their notes or warrants since the
date on which they provided information regarding their securities in
transactions exempt from the registration requirements of the Securities Act.
Information about the selling securityholders may change over time. Any changed
information given to us by the selling securityholders will be set forth in
prospectus supplements if and when necessary.

Shares of Common
Stock Beneficially
Owned Upon
Completion of
the Offering
Shares Shares of ----------------------
Shares Issuable Common Stock
Issuable on on Beneficially Number
Exchange Exercise Owned Before of
of Notes Class A Class B of Warrants the Offering Shares
Name (1) (2) Warrants Warrants (3) (4) (5) Percentage
-----------------------------------------------------------------------------------------------------------------------------------

Phoenix Bermuda L.P.* (6) 237,529 6,540,296 1,703,774 8,244,070 -- -- --
European Private Equity Investors
L.L.C.*(7) -- 459,704 119,755 579,459 -- -- --
GarMark Partners L.P.* (8) 570,588 -- -- -- -- -- --

-------------------------

* Denotes initial holder or its affiliate.

(1) Information concerning any change to the selling securityholders will be
set forth in prospectus supplements or post-effective amendments to the
registration statement from time to time, if required.

(2) Figures in this column assume that the selling securityholders will
exchange in full the notes held by them.

(3) Figures in this column assume that the selling securityholder will
exercise in full the warrants held by them and include the total number of
shares of common stock issuable upon exercise of the class A warrants and
the class B warrants.

(4) Figures in this column do not include the shares of common stock issuable
upon exchange of the notes or exercise of the warrants.

(5) Assumes that all securities offered by this prospectus are sold.

(6) Phoenix Bermuda L.P. is a Bermuda limited partnership whose sole general
partner is Compass Capital Partners Limited, a company incorporated in
Bermuda. Stephen Waters, Gavin Arton and James Keyes are directors of
Compass Capital Partners Limited and therefore may be deemed to have
shared voting and investment control with respect to securities held by
Phoenix Bermuda L.P. Messrs. Waters, Arton and

Keyes disclaim beneficial ownership of such securities except to the
extent of their pecuniary interest in them.

(7) The sole beneficial owner of European Private Equity Investors L.L.C. is
General Electric Pension Trust ("GEPT"), which is a pension trust for
employees of General Electric Company ("GE") and its subsidiaries. GEPT's
investment manager is GE Asset Management Incorporated, a registered
investment advisor and wholly-owned subsidiary of GE. GEPT may be deemed
to be an affiliate of a registered broker-dealer by virtue of the fact
that GEPT may be deemed to be "under common control" with any NASD members
affiliated with GE. In addition, individuals who are trustees of GEPT may
be directors or officers of registered broker-dealers that are affiliated
with GE. However, as an entity subject to ERISA, GEPT is operated solely
in the interest of its beneficiaries and, therefore, no GE entities other
than GEPT and its wholly-owned affiliates (none of which are NASD members)
have a beneficial or pecuniary interest in the securities being offered
under this registration statement.

(8) The general partner of GarMark Partners L.P. is GarMark Associates L.L.C.
E. Garrett Bewkes, III and Mark G. Solow are the managing members of
GarMark Associates and therefore these persons may be deemed to have
shared voting and investment control with respect to such shares.

None of the selling securityholders identified above are broker-dealers.

With respect to selling securityholders that are affiliates of
broker-dealers, such entities acquired their securities in the ordinary course
of business and, at the time of the acquisition of such securities, such selling
securityholders had no agreements or understandings, directly or indirectly,
with any person to distribute the securities. To the extent that we become aware
that such selling securityholders did not acquire their securities in the
ordinary course of business or did have such an agreement or understanding, we
will file a post-effective amendment to the registration statement of which this
prospectus is a part to designate such affiliate as an "underwriter" within the
meaning of the Securities Act.

None of the selling securityholders has had any position, office or other
material relationship with Vishay or any of our predecessors or affiliates
within the past three years.

Only selling securityholders identified above who beneficially own the
securities set forth opposite each such selling securityholder's name in the
foregoing table on the effective date of the registration statement of which
this prospectus is a part may sell such securities under the registration
statement. Prior to any use of this prospectus in connection with a sale or
offering of the common stock underlying the notes, the warrants or the common
stock underlying the warrants by any holder not identified above, the
registration statement of which this prospectus is a part will be amended by a
post-effective amendment to set forth the name and aggregate amount of
securities beneficially owned by the selling securityholder intending to sell
such securities and the amount of such securities to be sold or offered. The
prospectus that will be a part of such a post-effective amendment will also
disclose whether any selling securityholder selling in connection with such
prospectus has held any position, office or other material relationship with
Vishay or any of our predecessors or affiliates within the three years prior to
the date of such prospectus if such information has not been disclosed herein.

PLAN OF DISTRIBUTION

The selling securityholders and their successors, which include their
pledgees, donees, partnership distributees and other transferees receiving the
warrants, the notes or the common stock underlying the notes from the selling
securityholders in non-sale transfers, may sell the warrants and the common
stock underlying the notes directly to purchasers or through broker-dealers or
agents. The common stock underlying the notes may also be sold to underwriters
in a firm commitment underwriting. The initial holders of the warrants and their
affiliates may sell the warrants and the common stock underlying the warrants
directly to purchasers or through broker-dealers, agents or underwriters in a
firm commitment underwriting. Other holders of the warrants may only sell the
common stock underlying the warrants pursuant to the prospectus:

o in a firm commitment underwritten public offering, where the
warrants are being exercised in connection with the offering; or

o if for any reason our registration of the shares of common stock
issuable upon exercise of the warrants is not effective.

Underwriters, broker-dealers or agents may receive compensation in the
form of discounts, concessions or commissions from the selling securityholders
or the purchasers. These discounts, concessions or commissions may be in excess
of those customary in the types of transactions involved.

The warrants and the common stock underlying the notes and the warrants
may be sold in one or more transactions:

o at fixed prices;

o at prevailing market prices at the time of sale;

o at varying prices determined at the time of sale; or

o at negotiated prices.

These sales may be effected in transactions, which may involve crosses or
block transactions, in the following manner:

o on any national securities exchange or quotation service on which
the warrants or the common stock underlying the notes and the
warrants may be listed or quoted at the time of sale;

o in the over-the-counter market;

o in transactions other than on these exchanges or services or in
the over-the-counter market;

o through the writing and exercise of options, whether these
options are listed on an options exchange or otherwise; or

o through the settlement of short sales.

If a material arrangement with any broker-dealer or other agent is entered
into for the sale of any securities through a secondary distribution, block
trade, special offering, exchange distribution or a purchase by a broker or
dealer, or if other material changes are made in the plan of distribution of the
securities, a prospectus supplement will be filed, if necessary, disclosing the
material terms of such arrangement. If a material arrangement with any
underwriter is entered into, a post-effective amendment will be filed, if
necessary, disclosing the material terms of such arrangement. If necessary or
appropriate, the warrants or the common stock to be sold, the names of the
selling securityholders, the respective purchase prices and public offering
prices, the names of any agent, dealer or underwriter, any applicable
commissions or discounts and the other material terms and conditions of a
particular offer will be set forth in an accompanying prospectus supplement or,
if a distribution is to be effected in the form of a firm commitment
underwriting, a post-effective amendment to the registration statement of which
this prospectus is a part.

If underwriters are used in the sale, the securities being sold will be
acquired by the underwriters for their own account and distribution of the
securities may be effected from time to time in one or more transactions at a
fixed price or prices, which may be changed, in a firm commitment underwriting.
Unless otherwise set forth in the prospectus supplement with respect to the
securities being offered thereby, the obligations of the underwriters to
purchase such securities will be subject to certain conditions precedent and the
underwriters will be obligated to purchase all such securities if any of such
securities are purchased. The initial public offering price of any securities
and any discounts or concessions allowed or reallowed or paid to dealers may be
changed from time to time.

If dealers are used in the sale, unless otherwise indicated in the
prospectus supplement with respect to the securities being offered thereby, the
selling securityholders will sell such securities to the dealers as principals.
The dealers may then resell such securities to the public at varying prices to
be determined by such dealers at the time of resale.

Securities may also be sold through agents designated by the selling
securityholders from time to time or directly by the selling securityholders.
Any agent involved in the offering and sale of the securities in respect of
which this prospectus is being delivered will be named, and any commission
payable by the selling securityholder to such agent will be set forth, in the
prospectus supplement with respect to such securities. Unless otherwise
indicated in the prospectus supplement, any agent will be acting on a best
efforts basis for the period of its appointment.

Underwriters, dealers and agents who participate in the distribution of
the securities may be entitled under agreements entered into with the selling
securityholders to indemnification by the selling securityholders against
certain civil liabilities, including liabilities under the Securities Act, or to
contribution with respect to payments which the underwriters, dealers or agents
may be required to make in respect thereof.

Selling securityholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn engage in
short sales of the warrants or the common stock underlying the notes and the
warrants and deliver these securities to close out short positions or loan or
pledge the warrants or the common stock underlying the notes and the warrants to
broker-dealers that in turn may sell these securities.

The aggregate proceeds to the selling securityholders from the sale of the
warrants or common stock underlying the notes and the warrants will be the
purchase price of the warrants or common stock less any discounts and
commissions, if applicable. A selling securityholder reserves the right to
accept and, together with its agents, to reject, any proposed purchase of
warrants or common stock to be made directly or through agents. We will not
receive any of the proceeds from the resale of these securities by the selling
securityholders. We will, however, receive cash consideration in connection with
the exercise of the warrants.

In order to comply with the securities laws of some jurisdictions, if
applicable, the holders of warrants and the common stock underlying the notes
and the warrants may sell in some jurisdictions through registered or licensed
broker dealers. In addition, under certain circumstances in some jurisdictions,
the warrants may need to be registered or qualified for sale or comply with an
available exemption from the registration and qualification requirements of such
jurisdiction.

To our knowledge, there are currently no plans, arrangements or
understandings between any selling securityholders and any underwriter,
broker-dealer or agent regarding the sale of any securities by the selling
securityholders.

Our outstanding common stock is listed for trading on the New York Stock
Exchange. There is no established trading market for the warrants. We do not
intend to list the warrants for trading on any automated interdealer quotation
system or national securities exchange.

The selling securityholders and any underwriters, broker-dealers or agents
that participate in the sale of the warrants and common stock underlying the
notes and the warrants may be "underwriters" within the meaning of Section 2(11)
of the Securities Act. Any discounts, commissions, concessions or profits they
earn on any resale of the warrants or the shares of common stock underlying the
notes and the warrants may be underwriting discounts and commissions under the
Securities Act. Selling securityholders who are "underwriters" within the
meaning of Section 2(11) of the Securities Act will be subject to the prospectus
delivery requirements of the Securities Act. The selling securityholders have
acknowledged that they understand their obligations to comply with the
provisions of the Exchange Act and the rules thereunder relating to stock
manipulation, particularly Regulation M, and have agreed that they will not
engage in any transaction in violation of such provisions.

In addition, any securities covered by this prospectus that qualify for
sale pursuant to Rule 144 or Rule 144A under the Securities Act may be sold
under Rule 144 or Rule 144A rather than pursuant to this prospectus.

We entered into a securities investment and registration rights agreement
for the benefit of the holders of the notes and the warrants. Pursuant to this
agreement, we agreed to register the warrants and the common stock underlying
the notes and the warrants with the SEC under specific circumstances and for
specific times. In addition, the selling securityholders and we have agreed to
indemnify each other and our respective controlling persons against, and in
certain circumstances to provide contribution with respect to, specific
liabilities in connection with the offer and sale of the warrants and the common
stock underlying the notes and the warrants, including liabilities under the
Securities Act. We will pay the expenses incident to the registration of the
warrants and the common stock underlying the notes and the warrants, except that
the selling securityholders will pay all underwriting discounts, commissions or
fees attributable to the sale of the securities and will pay the costs of their
own counsel.

LEGAL MATTERS

The validity of the warrants and the common stock underlying the notes and
the warrants is being passed upon for us by Kramer Levin Naftalis & Frankel LLP,
New York, New York.

EXPERTS

The consolidated financial statements of Vishay Intertechnology, Inc.
appearing in Vishay's Annual Report (Form 10-K/A) for the year ended December
31, 2002, have been audited by Ernst & Young LLP, independent auditors, as set
forth in their report thereon included therein and incorporated herein by
reference. Such consolidated financial statements are incorporated herein by
reference in reliance upon such report given on the authority of such firm as
experts in accounting and auditing.

WHERE YOU CAN FIND MORE INFORMATION

We file annual, quarterly and current reports, proxy statements and other
information with the SEC. The file number under the Securities Exchange Act of
1934 for our SEC filings is No. 1-07416. You may read and copy materials that we
have filed with the SEC at the SEC's public reference room located at 450 Fifth
Street, N.W., Room 1024, Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330 for further information on the public reference room. Our SEC
filings also are available to the public on the SEC's web site at www.sec.gov,
which contains reports, proxies and information statements and other information
regarding issuers that file electronically.

This prospectus "incorporates by reference" information that we have filed
with the SEC under the Exchange Act, which means that we are disclosing
important information to you by referring you to those documents. Any statement
contained in this prospectus or in any document incorporated or deemed to be
incorporated by reference into this prospectus will be deemed to be modified or
superseded for purposes of this prospectus to the extent that a statement
contained in this prospectus or any subsequently filed document which also is,
or is deemed to be, incorporated by reference into this prospectus modifies or
supersedes that statement. Any statement so modified or superseded will not be
deemed, except as so modified or superseded, to constitute a part of this
prospectus. We incorporate by reference into this prospectus the following
documents that we have previously filed with the SEC and any future filings that
we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange
Act after the date of this prospectus until all of the securities covered by
this prospectus are sold by the selling securityholders:

o Our Annual Report on Form 10-K/A for the fiscal year ended December
31, 2002;

o Our Quarterly Report on Form 10-Q for the fiscal quarters ended March
31, 2003, June 30, 2003 and September 30, 2003;

o Our Current Reports on Form 8-K filed on January 23, 2003, August 1,
2003, August 8, 2003 and February 4, 2004 and Current Report on Form
8-K/A filed on February 26, 2003; and

o The description of our common stock set forth in our Registration
Statement on Form 8-A filed on December 27, 1983, including any
amendment or reports filed for the purpose of updating such
description.

You may request a copy of these filings at no cost, by writing or
telephoning us at the following address:

Vishay Intertechnology, Inc.
63 Lincoln Highway
Malvern, PA 19355
Attn: William J. Spires
(610) 644-1360

PART II

INFORMATION NOT REQUIRED IN THE PROSPECTUS

Item 14. Other Expenses Of Issuance And Distribution

The Registrant is paying all of the expenses related to this offering. The
following table sets forth the approximate amount of fees and expenses payable
by the Registrant in connection with this Registration Statement and the
distribution of the shares of the securities being registered hereby. The
selling securityholders will bear all underwriting discounts, commissions or
fees attributable to the sale of the registrable securities.

SEC registration fee $19,709.64
Legal fees and expenses 75,000.00
Accounting fees and expenses 15,000.00
Printing and engraving expenses 25,000.00
Miscellaneous 12,147.00
-----------
Total $146,856.64

Item 15. Indemnification of Directors and Officers

Section 145 of the Delaware General Corporation Law provides that a
corporation has the power to indemnify a director, officer, employee or agent of
the corporation and certain other persons serving at the request of the
corporation in related capacities against amounts paid and expenses incurred in
connection with an action or proceeding to which he is or is threatened to be
made a party by reason of such position, if such person shall have acted in good
faith and in a manner he reasonably believed to be in or not opposed to the best
interests of Vishay, and, in any criminal proceeding, if such person had no
reasonable cause to believe his conduct was unlawful; provided that, in the case
of actions brought by or in the right of Vishay, no indemnification shall be
made with respect to any matter as to which such person shall have been adjudged
to be liable to Vishay unless and only to the extent that the adjudicating court
determines that such indemnification is proper under the circumstances.

Vishay's certificate of incorporation provides that every person who is or
was a director, officer, employee or agent of Vishay shall be indemnified by
Vishay against all judgments, payments in settlement, fines, penalties, and
other reasonable costs and expenses resulting from any action, proceeding,
investigation or claim which is brought or threatened by or in the right of
Vishay or by anyone else by reason of such person being or having been a
director, officer, employee or agent of Vishay or any act or omission of such
person in such capacity. Such indemnification shall be available either if such
person is wholly successful in defending such action or if, in the judgment of a
court or the Board of Directors of Vishay or in the opinion of independent legal
counsel, such person acted in good faith in what he reasonably believed to be in
the best interests of Vishay and was not adjudged liable to the corporation,
and, in any criminal action, had no reasonable cause to believe that his action
was unlawful. In the case of a derivative action, such indemnification shall not
be made other than in respect of a court approved settlement or if, in the
opinion of independent counsel, the person satisfied the standard of conduct
specified in the prior sentence, the action was without substantial merit, the
settlement was in the best interest of Vishay and the payment is permissible
under applicable law. Directors may authorize the advancement of reasonable
costs and expenses in connection with any such action to the extent permitted
under Delaware law. Vishay's certificate of incorporation further provides that
no director shall have any personal liability to Vishay or to its stockholders
for any monetary damages for breach of fiduciary duty, to the extent permitted
under the Delaware General Corporation Law.

Vishay maintains $100 million of insurance to reimburse the directors and
officers of Vishay and its subsidiaries, for charges and expenses incurred by
them for wrongful acts claimed against them by reason of their being or having
been directors or officers of Vishay or any of its subsidiaries. Such insurance
specifically excludes reimbursement of any director or officer for any charge or
expense incurred in connection with various designated matters, including libel
or slander, illegally obtained personal profits, profits recovered by Vishay
pursuant to Section 16(b) of the Exchange Act and deliberate dishonesty.

II-1

Item 16. Exhibits

Exhibit No. Description
------------- ----------------------------------------------------------------
2.1 Share Sale and Purchase Agreement between Phoenix Acquisition
Company S.ar.l; Other Investors named therein; Mezzanine Lenders
(as defined); Vishay Intertechnology, Inc.; Vishay Europe GmbH;
and BCcomponents International B.V., dated as of November 10,
2002 (incorporated by reference to Exhibit 2.1 to our Form 8-K
filed on December 23, 2002).

2.2 Amendment to the Share Sale and Purchase Agreement between
Phoenix Acquisition Company S.ar.l; Other Investors as named
therein; Mezzanine Lenders (as defined); Vishay Intertechnology,
Inc.; Vishay Europe GmbH; and BCcomponents International B.V.,
dated as of December 4, 2002 (incorporated by reference to
Exhibit 2.2 to our Form 8-K filed on December 23, 2002).

3.1 Composite Amended and Restated Certificate of Incorporation of
Vishay.

3.2 Amended and Restated Bylaws of Vishay Intertechnology, Inc.
(incorporated by reference to Exhibit 3.2 to our Form 8-K filed
on August 8, 2003).

4.1 Warrant Agreement between Vishay Intertechnology, Inc. and
American Stock Transfer & Trust Co., dated December 31, 2002
(incorporated by reference to Exhibit 4.1 to our Form 8-K filed
on December 23, 2002).

4.2 Note Instrument by Vishay Intertechnology, Inc., dated as of
December 13, 2002 (incorporated by reference to Exhibit 4.3 to
our Form 8-K filed on December 23, 2002).

5.1 Opinion of Kramer Levin Naftalis & Frankel LLP regarding the
legality of the warrants and the shares of Vishay common stock
registered hereunder (incorporated by reference to Exhibit 5.1 to
our amendment no. 1 to our registration statement on Form S-3,
file no. 333-102507, as filed with the Securities and Exchange
Commission on August 8, 2003).

8.1 Opinion of Kramer Levin Naftalis & Frankel LLP regarding tax
matters (incorporated by reference to Exhibit 8.1 to our
amendment no. 3 to our registration statement on Form S-3, file
no. 333-102507, as filed with the Securities and Exchange
Commission on February 6, 2004).

10.1 Securities Investment and Registration Rights Agreement by and
among Vishay Intertechnology, Inc. and the Original Holders (as
defined), dated as of December 13, 2002 (incorporated by
reference to Exhibit 4.4 to our Form 8-K filed on December 23,
2002).

10.2 Note Purchase Agreement between Vishay Intertechnology, Inc. and
Subscribers (as defined), dated December 13, 2002 (incorporated
by reference to Exhibit 4.2 to our Form 8-K filed on December 23,
2002).

10.3 Put and Call Agreement between Vishay Intertechnology, Inc. and
the Initial Holders (as defined), dated as of December 13, 2002
(incorporated by reference to Exhibit 4.5 to our Form 8-K filed
on December 23, 2002).

23.1 Consent of Ernst & Young LLP.*

23.2 Consent of Kramer Levin Naftalis & Frankel LLP (included in
Exhibits 5.1 and 8.1).

24.1 Power of Attorney of all directors other than Zvi Grinfas
(incorporated by reference to Exhibit 24 to our amendment no. 1
to our registration statement on Form S-3, file no. 333-102507,
as filed with the Securities and Exchange Commission on August 8,
2003).

24.2 Power of Attorney of Zvi Grinfas (incorporated by reference to
Exhibit 24.2 to our amendment no. 3 to our registration statement
on Form S-3, file no. 333-102507, as filed with the Securities
and Exchange Commission on February 6, 2004).

* Filed herewith.

II-2

Item 17. Undertakings

(a) The undersigned registrant hereby undertakes:-

(1) To file, during any period in which offers or sales are being made,
a post-effective amendment to this registration statement;

(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events arising after
the effective date of this registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in this
registration statement. Notwithstanding the foregoing, any increase or
decrease in volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered) and any
deviation from the low or high end of the estimated maximum aggregate
offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b), if, in the aggregate, the changes in
volume and price represent no more than 20 percent change in the maximum
aggregate offering price set forth in the "Calculation of Registration
Fee" table in the effective registration statement; and

(iii) To include any material information with respect to the plan
of distribution not previously disclosed in this registration statement or
any material change to such information in this registration statement.

(2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.

(b) The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.

(c) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant, pursuant to the foregoing provisions, or otherwise,
the registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.

II-3

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Malvern, Commonwealth of Pennsylvania, on the 20th
day of February, 2004.

VISHAY INTERTECHNOLOGY, INC.

By: /s/ Dr. Felix Zandman
-----------------------------------
Dr. Felix Zandman
Chairman of the Board
and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this Amendment
No. 4 to the Registration Statement has been signed by the following persons on
February 20, 2004 the capacities indicated below.

SIGNATURE TITLE
-------------------------- --------------------------------------------------
/s/ DR. FELIX ZANDMAN Director, Chairman of the Board, and Chief
-------------------------- Executive Officer (Principal Executive Officer)
DR. FELIX ZANDMAN

/S/ * Executive Vice President, Treasurer and Chief
-------------------------- Financial Officer (Principal Financial and
RICHARD N. GRUBB Accounting Officer)

/S/ * Director
--------------------------
PHILLIPE GAZEAU

/S/ * Director
--------------------------
ZVI GRINFAS

/S/ * Director
--------------------------
ELI HURVITZ

/S/ * Director, President and Chief Operating Officer
--------------------------
GERALD PAUL

/S/ * Director
--------------------------
DR. ABRAHAM LUDOMIRSKI

/S/ * Director
--------------------------
DR. EDWARD B. SHILS

/S/ * Director
--------------------------
ZIV SHOSHANI

/S/ * Director
--------------------------
MARK I. SOLOMON

/S/ * Director
--------------------------
JEAN-CLAUDE TINE

/S/ * Director
--------------------------
MARC ZANDMAN

/S/ * Director
--------------------------
RUTA ZANDMAN

* By: /s/ Dr. Felix Zandman
----------------------
DR. FELIX ZANDMAN
as Attorney-in-Fact

[OBJECT OMITTED]

EXHIBIT INDEX

3.1 Composite Amended and Restated Certificate of Incorporation of
Vishay.

3.2 Amended and Restated Bylaws of Vishay Intertechnology, Inc.
(incorporated by reference to Exhibit 3.2 to our Form 8-K filed
on August 8, 2003).

4.2 Note Instrument by Vishay Intertechnology, Inc., dated as of
December 13, 2002 (incorporated by reference to Exhibit 4.3 to
our Form 8-K filed on December 23, 2002).

23.1 Consent of Ernst & Young LLP.*

23.2 Consent of Kramer Levin Naftalis & Frankel LLP (included in
Exhibits 5.1 and 8.1).

* Filed herewith.